Devices, systems, and methods for treating spinal cord injury with photobiomodulation via an implanted emitter

Implantable PBM emitters near the spinal column address the limitations of transcutaneous PBM by delivering targeted light therapy to treat SCI secondary damage, enhancing recovery with minimal side effects and thermal risk.

WO2026236756A1PCT designated stage Publication Date: 2026-11-12CASE WESTERN RESERVE UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/027666
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-09-15
Filing Date
2026-05-11
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Current treatments for spinal cord injury (SCI) secondary damage, such as inflammation and oxidative stress, face challenges including off-target effects, difficulty in implementation, high costs, and limited effectiveness, while transcutaneous photobiomodulation (PBM) is ineffective due to light absorption and scattering by skin, bone, and connective tissue.

Method used

Implantable emitters positioned near the spinal column deliver PBM directly to the spinal cord, using biocompatible devices with closed-loop control to optimize light dosage and minimize tissue damage, enabling targeted treatment of SCI secondary damage.

Benefits of technology

The implantable PBM system effectively reduces secondary SCI complications by stimulating mitochondria, increasing ATP production, and modulating cytokine expression, promoting significant recovery with minimal side effects and thermal damage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026027666_12112026_PF_FP_ABST
    Figure US2026027666_12112026_PF_FP_ABST
Patent Text Reader

Abstract

Photobiomodulation (PBM) can be applied to one or more target neural tissues within and / or near a patient's spinal cord via an implanted device that includes at least an emitter. The emitter (also referred to as a light emitting element) is implantable proximal to the spinal column of the patient near the site of the injury. At least the emitter can be secured in position relative the spinal column with specialized hardware and / or fixation mechanisms. The emitter can be within a hermetic package, within a catheter-like configuration, or the like. The target neural tissue can be irradiated with a dose of light for a time according to a prescription for PBM therapy. Parameters of the PBM / light can be controlled by an external controller in communication with the emitter.
Need to check novelty before this filing date? Find Prior Art

Description

PATENTDEVICES, SYSTEMS, AND METHODS FOR TREATING SPINAL CORD INJURY WITH PHOTOBIOMODULATION VIA AN IMPLANTED EMITTERRelated Applications

[0001] This application claims the benefit of U.S. Provisional Patent Application Serial Nos. 63 / 802,938 (filed May 9, 2025) and 63 / 881,684 (filed September 15, 2025), the entireties of which are hereby incorporated by reference for all purposes.Government Support

[0002] This invention was made with government support under 1937968 awarded by the National Science Foundation, and NS121372 awarded by the National Institutes of Health. The government has certain rights in the invention.Technical Field

[0003] This disclosure relates generally to treatment of spinal cord injury, and more specifically to systems and methods that apply one or more doses of photobiomodulation (PBM) to one or more target neural tissues within the spinal cord via at least an implanted emitter located near or within the spinal column.Background

[0004] Each year, approximately 18,000 people in the U.S. suffer a new Spinal Cord Injury (SCI). Depending on location and severity, SCIs can disrupt function in a patient’s somatic and / or autonomic nervous systems, leading to problems like motor and sensory loss, abnormal heart rhythm, respiratory issues, blood pressure problems, or the like. SCI damage occurs in two stages: unavoidable immediate mechanical injury and secondary damage due to inflammation, oxidative stress, ischemia, or the like, that unfolds over weeks. Current treatments for secondary damage focus on immobilization and physical therapy to promote wound healing and teach patients to live with the consequences of the SCI. Emerging experimental therapies (e.g., electrical stimulation therapies, cellular therapies, pharmacological therapies, or the like) aim to reduce inflammation and promote regeneration of damaged tissues. However, theseapproaches face numerous challenges, including but not limited to, off-target effects, difficulty in implementation, high costs, and limited improvement / effectiveness.Summary

[0005] Described herein are systems and methods that can provide photobiomodulation (PBM) therapy to one or more target neural tissues within a patient’s spinal cord via an implanted device that includes at least an emitter located near or within the spinal column. The PBM can treat, alleviate, and / or heal an injury within and / or near the spinal cord (e.g., secondary damage due to inflammation, oxidative stress, ischemia, or the like). In addition to the implanted device, the systems and methods also can include other implantable devices and implantation hardware, as well as several light source / emitter arrangements that can be connected to a controller for closed loop control of safe and efficacious PBM delivery.

[0006] In an aspect, the present disclosure can include a system comprising an intracorporeal device configured for implantation within a body of a patient, the device comprising at least one emitter configured to emit light to irradiate at least a portion of a spinal cord within a spinal column of the patient; one or more pieces of orthopedic hardware connected to the device, the one or more pieces of orthopedic hardware being sized and dimensioned for attachment to a location proximal to the spinal column; andan extracorporeal controller in electrical communication with the at least emitter and programmed to define a photobiomodulation (PBM) therapy delivered by the at least one emitter to the at least a portion of the spinal cord.

[0007] In another aspect, the present disclosure can include another system for delivering PBM to at least a portion of a spinal cord of a patient. The system can include at least one paddle shaped lead, at least one emitter, and a power source. The at least one paddle shaped lead can be flexible and configured to be positioned within a spinal canal of the patient. The at least one paddle shaped lead can have at least one surface configured to deliver light to at least one segment of the spinal cord of the patient. The at least one emitter can be coupled to the at least one surface of the at least one paddle shaped lead and can be configured to emit light of at least one wavelength. The power source can be configured to deliver power to the at least on emitter.

[0008] In a further aspect, the present disclosure can include an implantable paddle for delivery of PBM to a portion of a spinal cord. The implantable paddle can include two or more catheter components with at least one emitter on and / or within each of the two or more catheter components. The implantable paddle can also include a bioresorbable material holding the two or more catheter components.

[0009] In another aspect, the present disclosure can include a system that can be configured for implantation into a patient’s body to deliver PBM. The system can include at least one component that can include at least one light emitting element and at least one other component that can include a power source for the at least one component. The system can also include at least one light sensitive element that enables sensing of an amount of light being emitted by the light emitting element.

[0010] In a further aspect, the present disclosure can include a system for delivery PBM to at least a portion of a spinal cord of a patient. The system can include a percutaneous device and at least one light emitting element. The percutaneous device can have an internal portion under the patient’s skin, an interface portion that traverses the patient’s skin, and an external portion outside the patient’s skin. The percutaneous device can include at least one cable configured to connect to an external power and / or light source. The at least one light emitting element can be implanted in a spinal canal of the patient and positioned to cover an irradiation area of the spinal cord of the patient. The at least one light emitting element can be connected to the at least one cable to receive power and / or light from the external power and / or light source.

[0011] In another aspect, the present disclosure can include a method for delivering PBM to a portion of a spinal cord of a patient. The light emitting element can be implanted in the patient’s body proximal to a spinal column and near a site of a spinal cord injury. The light emitting element can be configured to emit light to irradiate at least a portion of the spinal cord within the spinal column. The injury site can be irradiated with a dose (of light) for a time according to a prescription to promote healing of the spinal cord injury. At least a portion of the light emitting element can be explanted after the prescription is complete.Brief Description of the Drawings

[0012] The foregoing and other features of the present disclosure will become apparent to those skilled in the art to which the present disclosure relates upon reading the following description with reference to the accompanying drawings, in which:

[0013] FIG. 1 is a block diagram of a system that can provide photobiomodulation (PBM) to at least a portion of a spinal cord of a patient via at least an implanted emitter;

[0014] FIG. 2 is a block diagram of one embodiment of the system of FIG. 1 with at least an implantable device that includes the emitter anchored in place by hardware;

[0015] FIG. 3 is a block diagram of a non-limiting example of the implantable device of FIG. 2;

[0016] FIGS. 4-7 include illustrations of non-limiting examples of hardware configurations for the implantable device of FIG. 2;

[0017] FIG. 8 is a block diagram of another embodiment of the system of FIG. 1 with at least one implantable paddle shaped lead with at least one emitter;

[0018] FIGS. 9 and 10 include illustrations showing examples of how the configurations of the implantable paddle shaped lead(s) of FIG. 8 can be implanted;

[0019] FIGS. 11 and 12 include illustrations showing examples of different light emitting schemes of the one or more emitters of the paddle shaped lead(s) of FIG. 8;

[0020] FIG. 13 includes illustrations showing example securement strategies of the paddle shaped lead(s) of FIG. 8;

[0021] FIG. 14 includes illustrations showing another example of the paddle shaped lead(s) of FIG. 8 that include catheter components connected with a bioresorbable material;

[0022] FIG. 15 is a block diagram of still another embodiment of the system of FIG.1 with a percutaneous interface;

[0023] FIG 16 is a block diagram of a further embodiment of the system of FIG. 1 ; and

[0024] FIG. 17 is a process flow diagram of a method for providing PBM to at least a portion of a spinal cord of a patient.Detailed DescriptionDefinitions

[0025] Unless otherwise defined, all technical terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure pertains.

[0026] As used herein, the singular forms “a,” “an,” and “the” can also include the plural forms, unless the context clearly indicates otherwise.

[0027] As used herein, the terms “comprises” and / or “comprising,” can specify the presence of stated features, steps, operations, elements, and / or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and / or groups.

[0028] As used herein, the term “and / or” can include any and all combinations of one or more of the associated listed items.

[0029] As used herein, the terms “first,” “second,” etc. should not limit the elements being described by these terms. These terms are only used to distinguish one element from another. Thus, a “first” element discussed below could also be termed a “second” element without departing from the teachings of the present disclosure. The sequence of operations (or acts / steps) is not limited to the order presented in the claims or figures unless specifically indicated otherwise.

[0030] It will be understood that when an element is referred to as being "on," "attached" to, "connected" to, "coupled" with, "contacting," etc., another element, it can be directly on, attached to, connected to, coupled with or contacting the other element or intervening elements may also be present. In contrast, when an element is referred to as being, for example, "directly on," "directly attached" to, "directly connected" to, "directly coupled" with or "directly contacting" another element, there are no intervening elements present. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.

[0031] As used herein, the term “spinal cord injury” or “SCI” can refer to damage to a patient’s spinal cord. SCIs can be complete or incomplete. SCIs can be caused by trauma, disease, degenerative disorders, or the like. One example of SCI can occur when vertebra(e) break or dislocate, causing pieces of the vertebra to tear into the spinal cord or press on the nerves of the spinal cord. SCIs can disrupt function in a patient’s somatic and / or autonomic nervous systems, leading to problems like motorand sensory loss, abnormal heart rhythm, respiratory issues, blood pressure problems, or the like. SCI damage occurs in two stages: unavoidable immediate mechanical injury and secondary damage due to inflammation, oxidative stress, ischemia, or the like, which unfolds over weeks.

[0032] As used herein, the term “spinal cord” can refer to a cylinder of nerves and other tissue covered in layers of meninges tissue that runs from a patient’s brain to lower back and carries nerve signals to and from the brain from and to the rest of the body. For example, the nerve signals can be from the somatic and / or autonomic nervous systems.

[0033] As used herein, the term “somatic nervous system” or “SNS” can refer to a part of the peripheral nervous system that is responsible for carrying sensory inputs to the brain and motor control commands to the muscles (e.g., skeletal muscles).

[0034] As used herein, the term “autonomic nervous system” or “ANS” can refer to a part of the peripheral nervous system that is responsible for control of involuntary bodily functions (e.g., that are not consciously directed), such as breathing, heartbeat, digestive processes, and the like.

[0035] As used herein, the term “vertebra” can refer to each of the series of small bones forming the backbone that have several projections for articulation and muscle attachment and a hole through which the spinal cord passes. Vertebrae is the plural of vertebra. Generally, humans have 33 vertebrae: 7 cervical, 12 thoracic, 5 lumbar, 5 sacral (fused into one sacrum bone), and 4 coccygeal (fused into one coccyx bone). Together, the vertebra can form a bony structure referred to interchangeably as the “vertebral column” or “spinal column”.

[0036] As used herein, the term “spinal canal”, also referred to as the “vertebral canal” or the “spinal cavity”, can refer to a cavity (hollow space) formed by the vertebral column that runs continuously through each of the vertebrae and contains the spinal cord. Cerebral spinal fluid can circulate around the spinal canal. The spinal canal can house and protect the spinal cord and other important structures, including blood vessels, meninges (protective layers), and the like.

[0037] As used herein, the term “photobiomodulation”, abbreviated as “PBM”, also referred to as “PBM therapy”, can refer to the delivery of one or more light signals at one or more prescribed wavelengths and dosing schemes to one or more portions of apatient’s spinal cord to achieve a desired physiological response (e.g., to treat and / or reduce secondary damage due to inflammation, oxidative stress, ischemia, or the like). PBM utilizes non-ionizing light sources, including lasers, light emitting diodes, and / or broadband light sources and can be delivered by one or more emitters. In some examples, the light can have a wavelength between 250 nm and 1600 nm. However, as an example, the wavelength can be in the visible range (e.g., from 400 nm to 700 nm) and / or near-infrared range (e.g., from 700 nm to 1100 nm) of the electromagnetic spectrum.

[0038] As used herein, the terms “dosing scheme”, “prescription”, and “PBM therapy” can be used interchangeably herein and can refer to a schedule of one or more doses of PBM (e.g., quantities of light of one or more wavelengths). A dosing scheme can include a time between doses of PBM, one or more times of day when the dose of PBM is to be given, a quantity of PBM to be delivered (a total per time period (hour, day, week, etc.) and / or per dose), a target intensity of the light signal(s) to reach the target area, a luminance of a light source of the PBM, a power associated with the delivery of the PBM and / or electrical stimulation, an amount of PBM in the dose estimated to reach the target area, or the like.

[0039] One embodiment of a dosing scheme is discussed below. In one example, a dosing scheme can comprise continuous wave light delivery (100% duty cycle).Optionally, pulsing can be employed for the purpose of managing heat generation and / or for interleaving wavelengths (such that only one wavelength or wavelength combination is on at a time) and / or for improving efficacy. In one example, an employed duty cycle can be 100% or a non-zero value less than 100% (e.g., at a resolution of 5's or 10's of percent). With regard to pulse widths, when pulses are used, the pulses can be about 10 ms to greater than 100 ms (e.g., about 1-5 seconds). With regard to irradiances, light can be delivered to a desired location so that the irradiances on and in the spinal cord tissue being treated are about 10 mW / cm2to about 500 mW / cm2, e.g., a non-zero value less than or equal to 100 mW / cm2. At the emitter, the irradiances can be higher to be able to reach the desired irradiances on or in the spinal cord. With regard to spot size, the emitter can deliver light to mechanically impacted tissue, and up to about 1-2 cm above or below the mechanically impacted tissue. Given this, a diffuser can typically be of length 5 mm, 10 mm, 15 mm, 20 mm, up to 30 or 40 mm, or up toabout 60 mm (e.g., which would account for a 2 cm injury and light applied 2 cm above and 2 cm below). With regard to initiation time, a first dose of light can be delivered as soon as possible after injury (e.g., less than 5 hours, less than 4 hours, less than 3 hours, less than 2 hours, less than 1 hour, less than 30 minutes or less than 10 minutes), for example, during a stabilization and decompression surgery. With regard to duration of therapy, at least one week, or up to two weeks, four weeks, six weeks, or 2-3 months can be employed. In one example, there are advantages (related to infection risk) if the device is percutaneous up to 29 days (<30 days) and then removed.

[0040] As used herein, the term “subcutaneous” can refer to something being situated or applied beneath (under) a patient’s skin. For instance, something located subcutaneously is located within the patient’s body under the skin. For example, the spinal cord is subcutaneous.

[0041] As used herein, the term “transcutaneous” can refer to something being delivered through / across a patient’s skin without physically disrupting the skin barrier.

[0042] As used herein, the term “percutaneous” can refer to something being delivered through the skin while disrupting a portion of the skin barrier. For example, percutaneous delivery can involve puncturing a patient’s skin.

[0043] As used herein, the term “patient” can refer to any warm-blooded organism, including, but not limited to, a human being, a pig, a rat, a mouse, a dog, a cat, a goat, a sheep, a horse, a monkey, an ape, a rabbit, a cow, etc. Generally, the term patient as used herein describes a human being but the systems, methods, and techniques described herein can also be used with respect to other warm-blood organisms (with any necessary small modifications).

[0044] As used herein, the terms “electrical communication”, “electrical connection”, and “electrically connects” can be used interchangeably and refer to the ability of a generated electric field to be transferred to, or have an effect on, one or more components of the present disclosure. In some instances, the generated electric field can be directly transferred to a component (e.g., via a wire or lead). In other instances, the generated electric field can be wirelessly transferred to a component. II. Overview

[0045] Spinal Cord Injuries (SCIs) can disrupt function of a patient’s nervous system (e.g., the somatic and / or autonomic nervous systems) with symptomsdepending on the location and severity of the SCI. SCI damage can occur in two stages: immediate mechanical injury and secondary damage from inflammation, oxidative stress, and ischemia. Secondary damage, which can unfold for weeks after the initial SCI, can be a main target for therapies. Current treatments focus on immobilization and physical therapy to promote wound healing and teach patients to live with the consequences of the SCI. Emerging and experimental therapies (e.g., electrical stimulation therapies, cellular therapies, pharmacological therapies, or the like) aim to reduce inflammation and promote regeneration of damaged tissues.However, these approaches face numerous challenges, including but not limited to, off-target effects, difficulty in implementation, high costs (i.e. , treatment costs can reach approximately $6 million per patient in many cases), limited improvement / effectiveness, and the like.

[0046] PBM is traditionally applied transcutaneously, but transcutaneous PBM cannot be used to treat SCI in humans at least because the spinal cord sits deep in a patient’s back, buried beneath layers of skin, bone, fat, and connective tissue. The multiple layers between the skin and spinal cord absorb and scatter large amounts of light - dramatically decreasing the amount of light that can reach the spinal cord. There is not a currently well-established method for applying light to the spinal cord that can bypass the problematic intervening tissue layers.

[0047] Described herein are systems and methods that can provide PBM therapy to one or more target neural tissues within a patient’s spinal cord via an implanted device that includes at least an emitter located near the spinal column. The PBM can treat, alleviate, and / or heal an injury within and / or near the spinal cord (e.g., secondary damage due to inflammation, oxidative stress, ischemia, or the like). The emitter can be positioned underneath the layers of obstructing tissues to reach the spinal cord. The emitter and any other implantable device should be biocompatible, easily implanted and explanted, and durable enough to be implanted for extended periods of time (weeks -months). For example, in addition to the emitter, an anchor, a power source, and / or a light source can fit within the body and / or the spinal column. Specific wavelengths of light can be emitted in specific irradiance patterns that enable even large sections of the spinal cord to be irradiated in a uniform or substantially uniform manner.III. Systems

[0048] PBM currently is not generally used clinically for SCI treatment at least because of issues related to effective implementation of the PBM. Most PBM that is used today is delivered to treatment target(s) via transcutaneous light application, which is not ideal for treating SCI. A patient’s spinal cord lies deep within the patient’s back under layers of skin, bone, fat, and connective tissue, all of which absorb and scatter a large amount of light, dramatically decreasing the amount of light applied through the skin that reaches the spinal cord. One traditional solution to increasing the amount of light (e.g., power, intensity, etc.) that reaches a treatment target is to turn up the power of the applied light. However, this traditional solution does not work for SCI treatments at least because the increased intensity would lead to thermal damage in the tissues between the skin and the spinal cord.

[0049] The system 100 of FIG. 1 overcomes the limitations caused by the obstructing and / or scattering layers between the skin and the spinal cord by emitting the light from a position more proximal to the spinal cord, without all of the skin, bone, fat, and connective tissues that plague transcutaneous application in the way, thereby decreasing the negative effects caused by the layers of skin, bone, fat, and connective tissue and avoiding the damage caused by increasing the power of the applied light. As discussed below, devices, systems, and methods of the present disclosure can advantageously be used for treating spinal cord injury (SCI), pain associated with the SCI, or other complications of the SCI. More specifically, PBM devices, systems, and methods can be used to treat secondary damage / complications from inflammation, oxidative stress, and ischemia that can unfold for weeks after an initial SCI. PBM can reduce the secondary complications, for example, by stimulating mitochondria, increasing ATP production, and reducing harmful inflammation. PBM can also shift macrophages and astrocytes to their anti-inflammatory states and can modulate cytokine expression, thereby contributing to significant recovery with minimal side effects.

[0050] The system 100 can include an emitter 102 (which can be one or more emitters but shown as a single emitter for ease of illustration) that can be implanted within a patient’s body proximal to a patient’s spinal column. As used herein, it should be understood that “proximal to” a patient’s spinal column can refer to adjacent to, on / touching, near, within, or the like the patient’s spinal column (although FIG. 1 doesnot show all possible configurations). The emitter 102 can be sized and dimensioned (and otherwise configured) to fit within the body of the patient proximal to the spinal column. The emitter 102 can emit light to irradiate at least a portion of a spinal cord within the spinal column for PBM therapy. For instance, the emitter 102 can effuse light of one or more wavelengths and / or intensities when electrically triggered. The emitter 102 can include one or more light sources (e.g., one or more light emitting diodes (LEDs), one or more laser diodes, a micro-diode array, or the like). It should be understood that the emitter 102 can also be referred to herein as a light emitter, a light source, or the like depending on the context.

[0051] The system 100 can also include an anchor 104 (also referred to in specific examples below as a device, a holder, at least a portion of hardware, a pad, or the like) that can hold the emitter 102 in place proximal the spinal column. The anchor 104 can be implanted in the patient’s body and can be positioned to hold the emitter 102 in an orientation to deliver the PBM to a treatment location (e.g., on, in, and / or related to the spinal cord, the spinal column, or the like). In some instances, the anchor 104 can further direct the light of the PBM (or at least help to direct at least a portion of the light of the PBM) to the treatment location. The anchor 104 can be sized and dimensioned (and otherwise configured) to fit within the body of the patient proximal to the spinal column and to hold the emitter 102. For example, the anchor 104 can be implanted at a certain location (e.g., a vertebral location, but is not limited to the vertebral location) to cause the emitter 102 to accurately and effectively emit light in a given direction and / or to a given treatment location. In some instances, the anchor 104 and the emitter 102 can be separate elements (as shown in FIG. 1). In other instances, the emitter 102 and the anchor 104 can be at least partially or fully embodied within the same element. In still other instances, the emitter 102 and a portion of the anchor 104 can be at least partially within the same element and at least another portion of the anchor 104 can be clearly separate elements.

[0052] While not shown in FIG. 1, the emitter 102 and anchor 104 can include various additional devices and / or parts to ensure the emitter is fixed in the correct place on or near the patient’s spinal column when implanted in the patient. For example, the emitter 102 can be anchored (by anchor 104) proximal to the site of injury (e.g., to one or more bones of the spinal column). The emitter 102 can be positioned such that atleast a portion of the light is delivered proximal to the site of injury (e.g., next to, above, below, or the like, the injury site itself) and completely to the site of the injury. In other instances, the emitter 102 can be positioned such that at least a portion of the light can be delivered to an area affected by the SCI that does not include the site of injury itself., For example, when the emitter 102 is implanted over the injury site itself, the light can be delivered to the injury site itself to promote healing while blocking invasion by glia and fibroblasts to support neuron survival and neural connectivity. In another nonexclusive example, the emitter 102 may be implanted proximal to, but not directly over, the injury site and the system 100 can treat one or more instances of secondary damage.

[0053] The emitter 102 and the anchor 104 can be implanted in an easily repeatable manner for maximum usage by surgeons. For instance, the emitter 102 and / or the anchor 104 can be attached on / to and / or positioned near one or more easily identifiable bony landmarks, the attachment mechanisms of the anchor can be easily manipulated, the size and dimensions of the emitter and / or the anchor can easily fit into the patient’s body, or the like. The emitter 102 and / or the anchor 104 can be configured to be easily removed from the patient’s body when treatment has finished without causing harm to the patient (e.g., minimizing infection risk, minimizing physical damage to tissues, or the like). Accordingly, the emitter 102 and / or the anchor 104 can be implanted into the patient and / or removed from the patient in a user-friendly manner. In some instances, the user-friendly manner can be non-surgical and / or minimally surgical. In other instances, the user-friendly manner can include one or more surgical procedures (but these surgical procedures can be simple and well-known to an average surgeon or neurosurgeon). In some instances, an emitter 102 can be removed and / or replaced while an anchor 104 can remain implanted in the patient.

[0054] The emitter 102 and / or the anchor 104 can be implanted for an extended period of time (e.g., days, weeks, months, or years). As an example, the extended period of time can be 1 day, 7 days, 15 days, 30 days, or more. The emitter 102 and / or the anchor 104 can be at least substantially biocompatible (e.g., can at least partially include biocompatible materials, can have an at least partially biocompatible housing and / or coating, or the like) and can be durable enough not to break at least over the extended period of implantation (e.g., titanium and / or titanium alloys, ceramics,polymers, or the like.). In other instances, at least a portion of the emitter 102 and / or the anchor 104 can be substantially bioabsorbable and / or bioresorbable. The system 100 can also dissipate heat generated by the emitter 102 irradiating tissues over the extended periods of time. The configuration of the emitter 102 and / or the anchor 104 (and / or one or more additional components, not shown in FIG. 1) can mitigate tissue damage due to the long term irradiation (discussed in more detail below).

[0055] The system 100 can also include a controller 106 that can communicate one or more parameters of one or more doses of the PBM therapy to the emitter 102. The controller 106 can be outside the patient’s body (also referred to as an “external controller” or “extracorporeal controller”) and can be communicably coupled to at least the emitter 102. In other words, the external controller 106 can be in communication with at least the emitter 102 via a wired and / or wireless connection (e.g., an RF connection). The wired connection between the controller 106 and the emitter 102 can be percutaneous and can pass through an opening in the patient’s skin. It should be appreciated, however, that, in some embodiments, the controller 106 can be located partly or entirely within a patient’s body (an “intracorporeal controller”).

[0056] It should be noted that if any portion of system 100 passes through the skin (e.g., a wire connecting the emitter 102 to the controller 106) there is an increased risk of infection at the site due to movement of the implant across the skin breaching the skin’s natural barrier. Additionally, the immune system of the human body can view implants as foreign entities and can attempt to separate / encapsulate them to protect the body from the foreign entities, which can affect the functionality of the system 100. Percutaneous implants, and fully implanted implants, can cause discomfort that can decrease the range of application of the implant and / or length of time an implant can remain implanted to provide treatment. As described in more detail below, further elements and / or specific configurations can be added to the system 100 (not shown in FIG. 1) to decrease the risk of infection and / or over-active immune response.

[0057] Referring again to the controller 106, the controller can include a processor 108 and a non-transitory memory 110. In other instances, the controller 106 can be / include a microprocessor with memory and processor abilities combined within a single device. The controller 106 can include a user interface 112 that can allow a user (e.g., a physician, a nurse, a physician’s assistant, a technician, or the like) to configurethe PBM to be delivered by the emitter 102 (also referred to as open loop control, allowing user definition of at least a portion of the PBM therapy). In other instances, the controller 106 can at least partially autonomously configure the PBM (also referred to as closed loop control). The processor 108 can access instructions (e.g., stored in memory 110) to execute at least one algorithm that defines at least a portion of the PBM therapy according to closed loop control. In some instances, the processor 108 can define the PBM in response to at least one signal from at least one sensor (e.g., any one or more sensors that provide information about the PBM and / or the area of the body receiving the PBM, not shown in FIG. 1) configured to detect a property of the human body of a patient. The closed loop control can optimize one or more outcomes associated with the PBM therapy and / or at least one parameter such as at least one wavelength, at least one intensity, at least one irradiance pattern, and / or the like. For instance, an irradiance pattern can be determined that enables large sections of the spinal cord to be irradiated uniformly (e.g., based on the different distances between the emitter and the treatment sites on the spinal cord and / or the types of tissues / physiological responses desired from the treatment).

[0058] As an example, the controller 106 can determine at least one parameter of the light applied to the spinal cord by the emitter 102. The at least one parameter of application can be determined according to one or more algorithms (the word “algorithm” refers to a set of rules to be followed, in some instances by a computer program, in calculations with one or parameters input as data) based on data specific to the patient (e.g., weight, height, gender, ethnicity, other medical conditions and / or injuries, desired outcomes, etc.), the injury (e.g., location, size, severity, etc.), the stage of recovery, or the like. The at least one parameter can include pulse type(s) (continuous and / or pulsed), time(s) of application, wavelength(s), intensity(is), area(s) irradiated, irradiance pattern(s), or the like. As an example, an optimized application of the light can include a one or more specific wavelengths of light used in specific irradiance patterns, enabling one or more sections (of varying size) to be irradiated uniformly. The controller 106 can define the application of the light across a plurality of treatment applications (e.g., with the same and / or different at least one parameters) that can make up the PBM therapy. For instance, to change wavelength(s) to triggerdifferent healing effects at different times, to change intensities and / or lengths of application to lower the risks of thermal damage, or the like)

[0059] The controller 106 may also include a power source 114. The power source 114 can provide power to the emitter 102 and / or to the controller 106. It should be understood that although the power source 114 is illustrated inside the controller 106 in FIG. 1, the power source may alternatively be located outside of the patient’s body and outside of the controller, or inside the patient’s body and outside the controller. In another instance, the power source 114 can be at least partially in the controller 106 and at least partially implanted in the patient’s body (such as a two part RF transmitter). Power can be transmitted from the power source 114 to the emitter 102 via the wired and / or wireless connection. The power source 114 can be a battery, an RF transmitter, a wall power source, or the like.

[0060] As has been previously noted, the system 100 can include one or more additional components and / or specific configurations of emitter 102, anchor 104, and / or controller 106 to provide PBM therapy to treat SCI. In some instances, the system 100 can include other implantable devices, implantation hardware, components, and / or arrangements of the emitter 102. These instances are described in detail below with reference to examples in FIGS. 2 - 15, which are intended to be illustrative and not exclusive.

[0061] In the example 200 shown in FIG. 2, the emitter 102 can be housed within a device 204 and the anchor 104 can be embodied within hardware 202. The device 204 is implantable (also referred to herein as “internal device” or “intracorporeal device”) and can be sized and dimensioned to fit within the body of the patient proximal to the spinal column and configured to attached to one or more pieces of orthopedic hardware (e.g., hardware 202) which can be anchored proximal to the spinal column. The emitter 102 of the device 204 can emit light to irradiate at least a portion of the spinal cord in the spinal column (e.g., to accomplish at least a portion of PBM therapy). The hardware 202 can aid in implantation of the device 204 in a position and / or orientation that can ensure the emitter 102 can irradiate a prescribed target site in the patient (e.g., within the spinal cord, associated with the spinal cord, etc.). Additionally, the hardware 202 described herein can be sized and dimensioned so that the hardware holds and positions the light emitter(s) 102 above the spinal cord so the light emitter(s) is / are notin direct contact with the spinal cord. In other words, the hardware 202 can be sized and dimensioned so that the emitter(s) attached to the hardware is / are suspended above the spinal cord, in a controlled position, so as to not be in physical contact with the spinal cord. Advantageously, the hardware 202 enables a high degree of control and precision for ensuring that the emitter(s) is / are 102 properly positioned relative to the desired target area(s) of the spinal cord, thereby ensuring safe and efficacious therapy delivery. Furthermore, the hardware 202 enables rapid and efficient system placement and operation, which is imperative following acute SCI. An example of the device 204 is shown in FIG. 3. Examples of the hardware 202 are shown in FIGS. 4-6. The controller 106 is the same as described above with respect to FIG. 1. The controller 106 can be an external controller in communication (wired and / or wireless) with at least the emitter 102 and / or a device associated with the emitter 102 to define the PBM therapy delivered by the emitter to the at least the portion of the spinal cord.

[0062] FIG. 3 shows one example 300 of the device 204. As previously noted, the device 204 can substantially or entirely house the emitter 102 (e.g., one or more LEDs, one or more laser diodes, etc.). The device 204 can be independently biocompatible and / or encased in a biocompatible material and implantable for an extended time period. For instance, the device 204 can be substantially or entirely encapsulated within one or more moisture-resistant or hermetic packages (one hermetic package 302 is shown in FIG. 3, but any type of moisture-resistant package can be used) that can provide the biocompatibility, for a time or indefinitely. It should be understood that the emitter 102, the device 204, and / or the moisture-resistant or hermetic package 302 can be biocompatible (for at least the length of the extended time period of implantation). For example, the time period can be at least 7 days, at least 14 days, at least 30 days, or longer.

[0063] The one or more hermetic packages can also include any moisture resistant packages that can be one or more sealed enclosures designed to be airtight and impervious to gas or moisture entrance / egress, ensuring long-term sterility, reliability and functionality of the emitter 102 and other packaged items (e.g., heat dissipater 304, attachment mechanism(s) 306, waveguide 308, RF coil 310, etc.). The one or more moisture-resistant or hermetic packages can remain implanted or can be removed (at the end of therapy or at any point time when desired, such as when atherapy complication exists). The one or more moisture-resistant or hermetic packages can, in some instance, direct the light from the emitter 102 to irradiate one or more locations within the at least the portion of the spinal cord.

[0064] For instance, the device 204 can include an optical feedthrough 312. In one instance, the optical feedthrough 312 can be entirely encapsulated by hermetic packages or moisture-resistant packages (e.g., hermetic package 302). In another instance, the optical feedthrough 312 can be partially encapsulated by one or more hermetic packages 302. Light can be delivered through the at least one of the one or more hermetic packages 302 via the optical feedthrough 312 and can be guided to irradiate the prescribed area of the patient. The optical feedthrough 312 can be a specialized device that allows for transmission of optical signals across a sealed barrier. For example, the optical feedthrough 312 can include a sealed transparent material, made from glass, or sapphire, transparent crystal (e.g., yttrium aluminum garnet- YAG), transparent ceramic (e.g., zirconia), transparent polymer (e.g., polycarbonate), photopolymer resins, or the like. The optical feedthrough 312 can be, for example, a fiber optic cable. In some instances, at least one of the one or more hermetic packages (or moisture-resistant packages) can additionally and / or alternatively include one or more waveguides 308 to aid in the transport and / or focusing of light (e.g., to generate a spot size, to ensure an amount of light travels to the spot, etc.). For example, an optical feedthrough 312 can interface with a waveguide 308 to receive the light (from the emitter 102) and deliver the light to the at least the portion of the spinal column. The waveguide 308 can provide a path that can guide light waves, minimizing energy loss during transmission. The waveguide 308 can be a structure that confines and directs the propagation of light. For example, the waveguide 308 can include one or more optical fibers, planar waveguides, channel waveguides, or the like. In some embodiments, the waveguide 308 can be designed to adhere to principles of total internal reflection for at least a portion of the waveguide.

[0065] As illustrated, the waveguide 308 can connect the emitter 102 and the optical feedthrough 312. It should be noted that the waveguide 308 can be shorter or longer than the distance between the emitter 102 and the optical feedthrough 312. The waveguide 308 can be at least partially protruding from the device 204 body, entirely inside the device body and / or entirely outside the device body attached to a surface ofthe device. The waveguide 308 can be entirely encapsulated by the hermetic package 302. The one or more waveguides 308 and / or the optical feedthrough 312 itself can include one or more diffusers, one or more lenses (including GRIN, Fresnel, cylindrical, Powell, etc.), one or more cylindrical light diffuser, one or more diffraction gratings, one or more line diffusers, one or more micro-lens arrays, or the like. As an example, the light can be focused or distributed to a spot size, which can be from 0.5 cm2to more than 15 cm2; power densities can be from 1 mW / cm2- 1 W / cm2, 1 mW / cm2- 200 mW / cm2, 800 mW / cm2- 1 W / cm2, or the like. Such treatments can be delivered over a period of one or more hours, one or more days, one or more months, or one or more years during the course of healing and / or adjunct therapy for the SCI.

[0066] In some instances, the emitter 102 can be coupled to other types of additional hardware (e.g., heat dissipater 304, attachment mechanism(s) 306, RF coil 310, etc.) that may be implanted within the patient’s body (e.g., within the device 204, within the hermetic package 302, and / or outside the device 204 and the hermetic package 210). It should be understood that any of the additional hardware may be within a different one or more hermetic packages or the same hermetic package(s). In some instances (not shown in FIG. 2), the device 204 and / or the hermetic package 302 can be housed within a tube-shaped device (e.g., an object with a hollow, cylindrical form). It should be understood that at least a portion of the tube-shaped device can enter / exit the body percutaneously (e.g., to allow electrical communication mechanisms and other components to enter and exit the patient’s body percutaneously). In some instances, the portion of the tube-shaped device can connect to an external light source (e.g., can include an elongated waveguide and / or optical feedthrough) and / or an external electrical source (e.g., can house one or more electrical cables that support powering the emitter 102) (not shown). It should be noted that the tube-shaped device can be attached, un-attached, and re-attached to devices outside the patient’s body as needed. Although not shown in FIG. 3, the system can also include a percutaneous interface that can facilitate the electrical connection between the device 204 and the controller 106.

[0067] The heat dissipator 304 (also referred to as a heat sink) can be within and / or on a surface of the device 204 and / or the one or more hermetic package 302, The heat dissipater 304 can be configured to dissipate heat generated by the emitter102 during and / or after use. It should be understood that the heat dissipator 304 can refer to one or more heat dissipators. The heat dissipator 304 can be designed to absorb heat generated by the emitter 102 and disperse the heat to prevent overheating of the device 204 and / or biological tissues of the patient. The heat dissipator 304 can be constructed with one or more materials with high thermal conductance (e.g., metals like aluminum, copper, or the like) to transfer heat away from at least the emitter 102 and, in some instances, one or more pieces of additional hardware of the device 204. For example, when transferring the heat away from at least the emitter 102 and, in some instances, one or more pieces of additional hardware, the heat dissipator 304 can transfer the heat into the surrounding environment (e.g., within the device 204, the one or more hermetic package 302, and / or outside the device and / or the one or more hermetic package (but away from the hot spots of device 204)). The design of the heat dissipator 304 can vary in complexity from simple metal fins to more complex devices.

[0068] The attachment mechanism 306, which can be within and / or on a surface of the device 204 and / or the one or more hermetic package 202, can aid in attachment of at least one part of the device and / or hermetic package 302, to an anchor and / or directly to a portion of a patient’s anatomy. For example, the attachment mechanism 306 can be an adhesive, a hardware component, or the like. In some instances, the attachment mechanism 306 can include at least a portion of the anchor 104 to aid in attachment of the device 204 and / or the hematic package 302 to the chosen location such that the emitter 102 can deliver a prescribed amount of light at one or more wavelengths to a treatment location. In some embodiments, the attachment device can aid in attachment to another hardware device, such as an orthopedic device.

[0069] As noted, the device 204 can be in communication with the controller 106 (as shown in FIGS. 1 and 2). An electrical signal can be delivered and / or received by at least a portion of the device 204 through a local electrical connection, a remote wireless connection, and / or an electrical feed through (shown only as a dashed line in FIG. 3 but can be any conductor used to carry a signal through an enclosure - e.g., through a catheter). The electrical signal can be sent from a remote device (e.g., controller 106) and can include information about the light therapy and / or prescription, power from a remote power source, or the like. The electrical signal can, additionally or alternatively, be sent from a local device (e.g., internal or attached to the skin) and can includeanything locally transmitted (e.g., instructions for the emitter 102, power to recharge a local battery, etc.). One or more hermetic packages can include electrical cabling to facilitate the electrical feedthrough and / or local transmission, for example. A wire can be connected to the electrical feedthrough (not illustrated) and can exit the patient’s skin percutaneously and form a connection between the device 204 and / or the hermetic package 302 and an external device (e.g., controller 106, power source 114, etc.). An electrical feedthrough can enable an electrical conductor to have one side inside a hermetic package and the other side outside the hermetic package. The feedthrough can be composed of one or more conductors that are sealed to a ceramic or similar material with a braze at high heat, such that there is a molecular bond between the materials and moisture and gas cannot breach the bond. The ceramic (or similar material) can also be brazed to the hermetic packages (e.g., a titanium can) so that moisture and gas cannot enter through that path. An optical feedthrough operates according to a similar mechanism but uses an optically transparent material.

[0070] As an example of a component that can send and receive the electrical signal, the device 204 can include an RF coil 310. The RF coil 310 can be within, remote from (but connected), and / or on a surface of the device 204 and / or the one or more hermetic package 202. The RF coil 310 can be a receiver of RF communication and / or a transmitter of RF communication. The RF coil 310 can be used to communicate (according to RF communication) with a device external to the patient (e.g., the controller 106, the power source 114, etc.). In this example, the device external to the patient can include another RF coil that can act as the transmitter / receiver and the RF coil 310 can act as a receiver / transmitter. As an example, the RF coil 310 can be used to receive information (e.g., related to light dose and / or parameters, patient information, or the like), power (e.g., RF power), or the like. It should be noted that in some instances, the device 204 can have a local implanted battery (not shown) that can be connected to the emitter 102 to directly power the emitter, and the battery can be a primary cell or RF power can be used to recharge the local implanted rechargeable battery.

[0071] FIGS. 4-6 show examples 400, 500, 600a, and 600b of the hardware 202 and the device 204 that includes at least the emitter 102. In each example, the device 204 can be held by the examples 400, 500, 600a, and 600b and the device cancommunicate with the controller 106. In some instances, the communication can be wireless, for example RF communication. In other instances, the communication can be wired, via a percutaneous wire. Although not shown, at least part of the device 204 can be encapsulated within the hermetic package 302.

[0072] In FIG. 4, the hardware 202 can be orthopedic hardware 402 that can be positioned on a portion of the spinal column. For example, the orthopedic hardware 402 can be positioned during a surgical procedure (e.g., a laminectomy, decompression surgery, stabilization surgery, or the like). At least a portion of the device 204 can be attached to the orthopedic hardware 402 during and / or after implantation of the orthopedic hardware (e.g., during the same procedure or a later procedure). The orthoptic hardware 402 can be sized and dimensioned to fit within the patient’s body proximal to the spinal column. The orthopedic hardware 402 can include one or more long rods running parallel to the spinal column and one or more cross-links connected to the one or more long rods (e.g., like a ladder). As an example, the orthopedic hardware 402 can be implanted to have the one or more cross-links span at least the vertebral level where a decompression surgery and / or a laminectomy has been performed (but can span further). The long rods and / or the cross-links can be screwed into place with pedicle screws (e.g., screw 406). Pedicle screws can be one or more types of surgical implants that can be used to stabilize vertebra and that are inserted into pedicles of the vertebra and then connected with the one or more rods to create a stable construct. The pedicle screws 406 may also be used to ensure that the device 204 and the emitter 102 are positioned correctly at a desired rostral / caudal and / or left right position along the one or more rods (e.g., shown relative one cross-link) such that light therapy can be delivered to a desired location. Pedicle screws 406 can also be used to hold the rods.

[0073] The device 204 can be, in this example, partially or entirely embodied within a hermetic package, and can be attached to the one or more rods at the desired rostral / caudal position proximal to the desired location. The device 204 can be positioned at a desired medial / lateral position along a cross-link using cross-link mechanism 404 (and can moved left / right to adjust light focusing to be midline or off-midline relative the spinal column). As an example (illustrated), the cross-link can span between the long rods (e.g., at regular intervals) and the device 204 can befixed / secured to one or more bars and / or between the bars via the cross link mechanism 404 (the cross-link mechanism can also be referred to as a cross link tool). The cross-link mechanism 404 can include one or more fasteners and / or a holding mechanism (e.g., at least one pedicle screw, at least one set screw-like device, at least one clamp, at least one press fit, at least one adhesive, and / or at least one nock-like device) configured to be secured to the one or more cross-links at one or more midline positions and / or one or more off mid-line positions relative to the spinal column. As another example, the device 204 can be affixed to one or more of the long rods using the cross-link mechanism 404 (similar to that described above) and the rostral / caudal focusing of the emitted light can be more fine-tuned. The crosslink mechanism 404, in either example, can be adjustable to allow the position of the device 204 to be adjusted in the rostral / caudal direction and / or the medial / lateral direction.

[0074] Similar to FIG. 4, in FIG. 5, the hardware 202 can be orthopedic hardware 402 placed during a surgical procedure as described above. In this example, the device 204 can be attached to and / or at least partially within a catheter 502 (also referred to as a tube-shaped device) (e.g., to allow electrical and / or light communication mechanisms and other components to enter and exit the patient’s body percutaneously and / or to more accurately direct light to a treatment site). For example, the catheter 502 can include one or more cables for electrical transmission and / or one or more waveguides. At least a portion of the device 204 or the catheter 502 can be attached to a cross-link and / or a long rod with at least one cross link mechanism 404 as described above. For instance, the one or more cross link mechanisms 404 can have specialized features to aid in securing the catheter 502 to position the device 204 and / or the emitter 102 to deliver light to a specific area. For example, the cross link mechanism 404 can include a holding mechanism (e.g., a set screw-like device, a clamp, a mechanical “teeth-like” device, a press-fit device, an adhesive, or the like) that can be secured in one or more midline and / or off-midline positions to enable the emitter 102 within the device 204 to deliver light more focused on the area being treated. Additionally, and / or alternatively The catheter 502 can run through one or more hoop connectors which can be connected to one or more cross-links of the orthopedic hardware 402. For example, the hoops can be positioned such that the fiber optic cable can be passed through the one or more hoops and secured to limit movement (e.g., like a set screw).

[0075] FIG. 6 shows two examples of mounting systems 600a, 600b (not drawn to scale) that can directly connect the device 204 to one or more vertebra to position the emitter 102 above the spinal cord. In example 600a, mounting hardware 602 can be attached to one or more transverse processes of the vertebra (e.g., after a laminectomy) by one or more biocompatible devices, such as biocompatible screws and / or adhesives (not shown). In example 600b, mounting hardware 604 can be wrapped around the sides of the vertebrae (e.g., after a laminectomy) and be secured to one or more sides of the vertebrae (e.g., one or more sides of the mounting hardware can secure itself by clamping onto one or more sides of the vertebrae and may or may not require the use of additional securing hardware).

[0076] Another embodiment of a mounting system 600c that can directly connect to one or more vertebra 624 to position one or more waveguides 308 above the spinal cord (e.g., following one or multi-level laminectomy 622). In example 600c, the mounting system 600c can comprise elongated, oppositely disposed rods 610 positioned about the vertebral column at a desired rostral / caudal position proximal to the desired location (e.g., a target location or locations comprising a portion or portions of the spinal cord meant to receive PBM therapy). Each of the elongated rods 610 can comprise a plurality of locations for receiving a screw 406 (e.g., a pedicle screw), as described herein. Extending transverse to each of the elongated rods 610 can be first and second sets of cross-linking arms 612 and 614. The first and second sets of crosslinking arms 612 and 614 can be vertically spaced apart from one another by a vertical distance VD. As shown in FIG. 6C, the second set of cross-linking arms 614 comprises an upper arm 614a and a lower arm 614b that physically overlap and are in axial alignment with one another. As shown, a lower surface 616 of the upper arm 614a can be in direct physical contact with an upper surface 618 of the lower arm 614b. The upper and lower arms 614a and 614b can be secured to one another via pins 620 that vertically extend through the upper arm 614a and at least a portion of the lower arm 614b. Although not shown, it will be appreciated that the first set of cross-linking arms 612 can have an identical or similar configuration as the second set of cross-linking arms 614. Connected to each of the first and second sets of cross-lining arms 612 and 614, and extending longitudinally across the vertical distance VD, is at least one (e.g., a plurality) waveguide 308 (as described herein). As shown in FIG. 6C, two isodiametriccylindrical waveguides 308 are positioned in parallel to one another and extend longitudinally across the vertical distance VD so as to provide PBM therapy to the desired location when activated (e.g., by a controller 106). As also shown in FIG. 6C, the at least one waveguide 308 can be in electrical connection with a controller 106 (e.g., located at an extracorporeal location). PBM therapy can applied to the desired location as described herein. Although the light emitting device illustrated in FIG. 6C is a pair of waveguides 308, it will be appreciated that any of the light emitting devices disclosed herein can additionally or alternatively be used with the system 600c.

[0077] FIG. 7 shows an example of various of the components described above in one system 700 in a percutaneous configuration. The emitter 102 can be positioned outside of the patient’s body, in this case, and light for the PBM therapy can be directed to a treatment site of the spinal cord and / or spinal column through a fiber optic cable 712 within a catheter 502 (or other tube-shaped device). The catheter 502 can be connected using a transcutaneous port 702 (which may be one or more ports, only one shown for ease of illustration) and can be held in place within a through-hole of a vertebral clamp 710 (or another type of vertebral fixation device). The port 702 can be created on a patient’s skin, following a laminectomy or other surgical procedure. The vertebral clamp 710 can be positioned relative to at least a portion of a vertebrae and can include at two serrated clamps that can grip the vertebrae at a specific narrowing point, creating a friction-fit for secure attachment with a compact posterior-screw design. The vertebral clamp 710 can be adjusted (tightened / loosened) with fixation screws 708 on each side of the through-hole that catheter 502 can be positioned within. The through-hole of the vertebral clamp 710 can optionally include a transparent and / or diffusing window 706 at the distal end (Which may be part of the clamp or the catheter) and may include an adhesive (not shown) (e.g., silicone glue or the like) for holding the catheter 502 in place a fixed distance from the dura (not shown for ease of illustration). The vertebral clamp 710 can include one or more additional posterior slots to fit various spinal column sizes (e.g., can be widened or narrowed). The vertebral clamp 710 can be made from polyetheretherketone or another rigid, bio-inert polymer. The catheter 502 can optionally include a transparent and / or diffusing window 706. The fiber optic cable 712 can include a diffuser tip 704 that can disperse light throughout the spinal cord and / or spinal column. For example in a rodent experiment, the light can be evenlyscattered over an angle greater than 220 degrees, covering an area of 1 cm2at a 2 mm distance from the distal tip of the fiber optical cable 712 / catheter 502. It should be understood that the angle can be any angle greater than zero depending on the composition of diffuser 704 and the area of light dispersion can be smaller or larger depending on factor such as the diffuser, the distance between the tip and the treatment site, the intensity of the light, the wavelength of the light, or the like. For a human patient, as an example, the light can be evenly distributed above and below the injury by 1 cm or less, 2 cm or less, 4 cm or less, 8 cm or less, 10 cm or less, 20 cm or less, or the like. The width of the light delivery can cover at least a part or all of the width of the spinal cord, for instance the width of light delivery can be between 0.01 mm and 15 mm, such as 1 mm, 5 mm, 10 mm, or 15 mm.

[0078] FIG. 8 illustrates another example system 800 that includes at least one paddle shaped lead 802 (serving as anchor 104). The at least one paddle shaped lead 802 can be flexible and can be shaped and / or sized to be positioned within the spinal canal of a patient so that at least one surface can deliver light to the spinal cord (e.g., at least one segment of the spinal cord, an area associated with the spinal cord, etc.). At least one emitter 102 can be coupled to and / or housed on and / or within each of the at least one light delivering surface of the at least one paddle shaped lead 802. The at least one emitter 102 can emit light of at least one wavelength to irradiate a treatment site in the patient (e.g., within the spinal cord, associated with the spinal cord, etc.). The system 800 can also include a power source 804 that can be coupled to the at least one emitter 102 to deliver power to the at least one emitter. As shown the power source 804 may be part of the at least one paddle shaped lead 802. The at least one paddle shaped lead 802 may also include a heat management mechanism 806 that can reduce the likelihood of thermal damage to the system 800 or surrounding bodily tissues. The heat management mechanism can be, for example, a material having a high thermal conductivity, at least one thermally conductive element, a hydrogel coating, and / or a phase change material. Additionally, the emitter(s) 102 and / or other portions of the paddle shaped lead 802 may be connected to a controller 106 that can define the PBM therapy and / or at least one parameter of the light (as described above).

[0079] The emitter(s) 102 can be a light source, such as laser diodes, light emitting diodes (LED), micro-LED arrays, or the like, or the emitter(s) 102 can be an opticalelement (e.g., a light pipe, an optical fiber, etc.) that can emit light generated by a remote light source to a targeted location. The emitter(s) 102 can comprise a single light source or multiple sources of the same or different light (e.g., a light emitting array). The emitter(s) 102 can emit light at one or more wavelengths (e.g., the same and / or different wavelengths at the same and / or different times). In addition to being coupled to power source 804 the emitter(s) 102 may be coupled to one or more diffusers (e.g., shown as diffuser 504) or other light transmission mechanisms. The diffuser(s) 504 associated with the emitter(s) 102 can achieve uniform distribution of the light across at least one treatment site (e.g., across at least one segment of the spinal cord). Depending on the configuration of diffuser(s) 504, each diffuser can provide a narrow beam for focused light delivery or a wide beam for more diffuse / larger coverage. In one example, the diffuser(s) 504 can include at least one optical fiber having an angled tip and / or tipped with a diffusing element. In other instances, the paddle shaped lead 802 itself can be at least partially a diffuser and no additional diffuser 502 may be needed.

[0080] As noted, the emitter(s) 102 can be coupled to the power source 804 to receive power. Although power source 804 is illustrated as being within the paddle shaped lead 802, it should be understood that the power source may be external to the patient’s body and / or internal to the patient’s body, to deliver power to the emitter(s) 102. In some instances, at least a portion of the power source 804 can be within the paddle shaped lead 802 (as shown). In other instances, at least a portion of the power source can be in a position under the patient’s skin, on the patient’s skin, and / or remote from the patient. As an example, the power source 804 can facilitate RF power (described above) from an external device to an internal device. As another example, the internal device may be an internal battery, which can be recharged in some instances by an external device (e.g., through RF power and / or an electrical cable). It should be understood that one or more electrical cables (attached to the one or more emitters, the paddle shaped electrode 802, and / or another device inside the patient’s body), can pass through the patient’s skin and be employed as described above. It should be understood that one or more electrical cables can be connected on the dorsal side of the paddle shaped lead 802 (not touching the spinal cord), and / or at the rostral and / or caudal end of the paddle shaped lead.

[0081] The body of the at least one paddle shaped lead 802 can include at least one material that is flexible to adapt to at least a portion the patient’s spinal cord and / or spinal column (e.g., at least one segment of the patient’s spinal cord). The surface of the paddle shaped lead 802 can be hermetically sealed and / or at least partially coated with one or more coatings. In some instances, components not completely encompassed inside a paddle shaped lead (e.g., emitter(s) 102, diffuser(s) 504, power source 804, heat management mechanism 806) of system 800 that may touch the patient’s body can also be hermetically sealed and / or coated. The coating can have a higher index of refraction than the at least one paddle shaped lead (e.g., than the base material) and can enable a uniform irradiation pattern of the emitted light. The at least one paddle shaped lead 802 can have a number of different configurations of length, width, thickness, number of leads, number of light delivering surfaces, and the like. Examples in FIGS. 9-14 show a variety of examples of systems with paddle shaped lead(s) in a plurality of views.

[0082] FIG. 9 shows two views of a single paddle shaped lead 902 that is wider and longer than thick. FIG. 9, element A shows a front view of a section of spine with the paddle shaped lead 902 and FIG. 9, element B shows a side view of the same section of spine with the paddle shaped lead 902. It should be understood that that the illustrations 900a and 900b, particularly anatomical components, are not intended to be anatomically correct and / or to scale and are merely representative to aid in description. The vertebrae that are present after the laminectomy are illustrated with dashed lines, as is the spinal cord, for ease of illustration. The paddle shaped lead 902 can be sized and dimensioned to be placed within the epidural space of the spinal canal (e.g., via a laminectomy - a surgical procedure where at least a portion of the lamina (the back part of one or more vertebra) is removed to relieve pressure on the spinal cord or nerves - or other type of decompression surgery). The paddle shaped lead 902 can be inserted through the laminectomy hole. As illustrated, the paddle shaped lead 902 can span two or more segments of the spinal cord. However, the size of the device can vary based on the application and / or the size of the patient’s specific SCI. Alternatively, instead of being placed with a laminectomy or decompression surgery the paddle shaped lead 902 can be positioned using cannulas without removing the lamina. The side facing the spinal cord can be configured to irradiate the treatment site with light.Additionally, while not shown in FIG. 9, any wired and / or other physical connection (e.g., catheter, light pipe, etc.) to a controller (e.g., controller 106) or other outside of the spinal column device (remote light source, power source, etc.) can extend through the space created by the laminectomy.

[0083] FIG. 10 shows two views 1000a and 1000b (top, element A and front, element B) of an alternative example system with paddle shaped leads 1002 that are long and thin (e.g., longer than wide). While three paddle shaped leads 1002 are shown, it should be understood that the number can be any number one or greater. The dimensions can further depend on the placement, size, and / or severity of the SCI In this example, a laminectomy or other decompression surgery can be avoided because the long, thin paddle shaped leads 1002 can be implanted using tools and techniques similar to those used to implant electrical spinal cord stimulators. As shown, the long, thin paddle shaped leads 1002 can be positioned side-by-side around at least portion of the spinal column. The long, thin paddle shaped leads 1002 can have a narrower profile than the paddle shaped leads 902, 1102, 1202, etc. but can still have the features described with respect to those leads as well as general paddle shaped lead(s) 802.

[0084] For instance, each of the long, thin paddle shaped leads 1002 can include one or more emitters (e.g., LEDs, micro-LEDs, or the like) that can be each individually connected to a power source and / or a light tunnel. In some instances, at least one of the paddle shaped leads 1002 can be a cylindrical light diffuser. The thin paddleshaped leads can be implanted and placed side-by-side within the patient’s spinal canal (and may be against the spinal cord, as shown in examples 1000a and 1000b).Additionally, while shown in a lined-up vertical configuration of three identical shapes, it should be understood that each of the paddle shaped leads 1002 may be offset from at least one other, placed at any angle relative the direction of the spine, and / or can have different lengths and / or widths (while the length remains longer than the width). Another advantage of the one or more thin paddle shaped leads 1002 can be that the one or more thin paddle shaped leads may be at least partially removable without requiring additional major surgery.

[0085] FIGS. 11-12 show further examples 1100a, 1100b, 1100c, 1200a, 1200b of paddle shaped leads 1102 and 1202. FIG. 11 shows paddle shaped leads 1102 that can utilize multiple indices of refraction to make use of the principle of total internalreflection to enable a uniform irradiation pattern over a given surface area. FIG. 11, element A shows a side view 1100a of a paddle shaped lead 1102 and FIG 11 , element B shows a front view 1100b of the same paddle shaped lead 1102. Each of the paddle shaped leads 1102 can have a body made of a high index of refraction material (generally referred to as internal material, N2 (shown dotted in 1100b because internal)).

[0086] The portion of the paddle shaped lead 1102 made of the high index of refraction material (N2) can be at least partially encased in one or more materials with lower indices of refraction (generally referred to as external material, N1). It will be understood that the terms lower and higher are meant to be used in comparison to each other (e.g., the index of refraction of N2 is always greater than the index of refraction of N1). In some instances, at least a portion of the external material and / or the internal material can include one or more bioabsorbable material to limit the complexity and / or the necessity of explant of the paddle shaped lead 1102. The internal material (N2) can be connected to one or more light sources (external or internal, such as LED, laser diodes, etc.) and can allow light to disperse through the internal material (N2). Channels and / or ports 1104 can be cut (or otherwise created) in the outer material N1 that expose portions of the internal material N2 to allow the light to pass out of the paddle shaped lead 1102 in desired locations. The channels and / or ports 1104 can guide the light out of the paddle shaped lead 1102. The channels and / or ports 1104 can be made of the external material (N1) to direct the light outward via the total internal reflection to one or more locations. FIG. 11, element A and element B, show the channels and / or ports 1104 in an array and / or a row but this is only for ease of illustration. It should be understood that the channels and / or ports 1104 can be in different numbers, shapes, sizes, and / or configurations and on one or more sides chosen to best fit the use to treat the SCI. In some embodiments, the channels include microlenses or simply are filled with the N2 material.

[0087] FIG. 11, element C shows another configuration of the paddle shaped lead 1102 where the paddle comprises a plurality of channels 1104 (of internal material, N2) that are each at least partially encased in the outer material (N1) and / or a coating to guide the light to locations on at least one light delivering surface of the paddle. In this way less internal material N2 may need to be used. The channels 1004 can be entirelyviewable from the light delivery side (as shown) and / or can be at least partially enclosed (e.g., with holes positioned in N1 above the N2 channels).

[0088] In each of the examples of FIG. 11 , light can enter the paddle shaped device through light tunnels (e.g., at one or more long ends of the surface) not touching the patient’s spinal cord. In some instances, there may be more and / or alternative light tunnel inputs into the low refractive material (creating the channel(s)) to allow the light to pass through to the location.

[0089] FIG. 12 shows different example views 1200a, 1200b of a paddle shaped lead 1202 that includes one or more light emitting array, e.g., LED or micro-LED 1204 arrays embedded in a paddle shaped lead 1202 (e.g., the emitter(s) are one or more LED or micro-LED 1204 arrays (it should be understood that micro-LED can be interchanged with LED in the description below). It should be noted that paddle shaped leads 1202 can be coated with a moisture-resistant coating, such as parylene. FIG. 12, element A shows a front view of a paddle shaped lead 1202 with a plurality of micro-LED 1204 arrays embedded in a light delivering surface and FIG. 12, element B shows a side view of the paddle shaped lead 1202. The paddle shaped lead 1202 can be sized and / or shaped to be placed directly on and / or near the spinal cord for delivery of light in a targeted / spatially controlled manner. The paddle shaped lead 1202 can have a substrate 1204 (flexible or rigid). The micro-LED 1204 arrays can be at least partially embedded into the substrate 1204 (flexible or rigid). It should be noted that flexible substrates are emerging as a powerful tool for optogenetic stimulation and photobiomodulation because of the small size and ability to be placed directly on and / or near more complex treatment sites. Each of the micro-LED 1204 arrays can include at least two micro-LEDs to deliver light. Each of the at least two micro-LEDs 1204 of the micro-LED arrays can deliver light of the same and / or different wavelengths at concurrent and / or different times. For example, one or more micro-LEDs 1204 can deliver blue light while another one or more micro-LEDs can deliver infrared light for the same and / or different times. The use of micro-LED 1204 array(s) can provide precise spatial control over where light is delivered as part of the PBM therapy. In some instances, the micro-LED array can include heat management safeguards (including using heat management mechanism 806 shown in FIG. 8). For example, the paddle shaped lead 1202 with micro-LED 1204 array(s) can have a heat managementmechanism that can include one or more materials having a high thermal conductivity, like silicon carbide, sapphire, etc.; at least one thermally-conductive element, like metal traces or heat sinks; one or more hydrogel coatings; one or more phase change materials; or the like. Additionally, the micro-LED 1204 array(s) can be programmed with an on / off scheme with different micro-LEDs on or off at different times to deliver pulsed light to reduce spot heating.

[0090] The paddle shaped lead 1202 can also include one or more diffusers 1208 (also described with respect to 504). At least one diffuser 1208 can be associated with at least one micro-LED 1204 (shown as one diffuser over all the micro-LEDs in FIG. 12, element B) to achieve uniform distribution of light across at least one segment of the patient’s spinal cord. Micro-LED 1204 are small, discrete light sources. Without a diffuser 1208, light emitted by each micro-LED 1204 has the potential to produce hot spots (areas of higher irradiance) on the tissue or surface being illuminated for PBM therapy. The diffuser 1208 can help to spread the light emitted from the micro-LEDs 1204 evenly across a broader area, providing a more uniform irradiance. The diffuser 1208 can aid the micro-LED 1204 array to illuminate a larger surface area by spreading the light from each individual micro-LED. This can be helpful in situations where the treatment site is an entire region that needs to be illuminated (e.g., a portion of the spinal cord) rather than one or more small spots. Diffusers come in various types and can be tailored to the specific beam pattern needed (e.g., a wide beam with more diffuse coverage may be preferred over a narrow, focused beam - or vice versa - for light delivery).

[0091] FIGS. 13-14 include illustrations showing different non-limiting examples 1300a, 1300b, 1300c, 1400a, 1400b of how paddle shaped leads can be secured within the spinal column (e.g., to one or more vertebra or the spinal cord). FIG. 13 shows examples 1300a, 1300b of adding targeted high friction elements 1304 to a portion of paddle shaped lead 1302 to secure the paddle shaped lead in position. A surface of the paddle shaped lead 1302 can have a material thereon that acts as a targeted high friction element 1304 to provide friction between at least one (non-light delivering) surface of the paddle shaped lead and a portion of the spinal canal to prevent migration of the paddle shaped lead. In some instances, the high friction element 1304 can be made of a bioabsorbable material that decreases the friction over time (e.g., asabsorbed) enabling easier explant and / or removal. As shown in FIG. 13, element A, in example 1300a, a high friction element 1304 can be positioned between the ventral side of the paddle shaped lead 1302 and the dura (not shown) on / around the vertebra to create friction between the ventral side and the dura. As shown in FIG. 13, element B, in example 1300b, the high friction element 1304 can be positioned on a dorsal side of the paddle shaped lead 1302 between the dorsal side and the spinal canal / spinal cord to create friction between the dorsal side and the spinal canal / spinal cord.

[0092] FIG. 13, element C, shows an example 1300c of paddle shaped lead 1302 that can include tether points for securing the paddle shaped lead in position. One or more tether points 1306 can be built into the paddle shaped lead 1302 to secure the paddle shaped lead in place. Four tether points 1306 positioned in the corners of the paddle shaped lead 1302 are shown in example 1300c, but it should be understood that any number and configuration that is sufficiently secure can be utilized. Sutures or another type of biocompatible tethering material can be threaded through the tether points 1306 and attached to one or more natural anatomical tether points in the surrounding tissue and / or artificially created tethering points in the surrounding tissue. Additionally, in some instances the paddle shaped lead can include one or more sensors 1308 in various locations on and / or within the paddle shaped lead or connected to the cable related to the paddle shaped lead. For example, the one or more sensors 1308 can include at least one light sensitive element (e.g., at least one photodiode) that can sense an amount of light being emitted by the one or more emitters.

[0093] FIG. 14, element A shows a front view 1400a of another example implantable paddle shaped device 1410 and FIG. 14, element B shows an implanted side view 1400b of the implantable paddle device. The implantable paddle shaped device 1410 can include two or more catheter components 1402 and a bioresorbable material 1406 (e.g., a bioresorbable suture) holding the two or more catheter components in positions relative to one another. The two or more catheter components 1402 can be sized and dimensioned to be placed within the patient’s spinal canal. The two or more catheter components 1402 can otherwise be in any size, shape, configuration, and / or relative orientation of two or more that a person of ordinary skill in the art deems proper for providing PBM therapy to treat a given SCI. As an example,the two or more catheters and / or catheter-like components can be arranged in the patient’s spinal canal such that the at least one emitter on each catheter component is arranged in a fixed relative spatial orientation to another. As shown in FIG. 14, element B, the paddle shaped device 1410 can be positioned epidurally over the patient’s spinal cord (e.g., positioned relative to a spinal cord injury or area requiring treatment related to the spinal cord injury). The paddle shaped device 1410, in some instances, can be placed and / or positioned during a surgical procedure (e.g., laminectomy or other procedure as described above). However, in other instances, the paddle shaped device 1410 may be placed without requiring the laminectomy or other procedure, as also described above. The bioresorbable material 1404 can at least partially resorb into the body of the patient after a time (e.g., the time of the treatment or longer). After the bioresorbable material has been resorbed, the two or more catheter components 1402 of the paddle shaped device 1410 can be removed from the patient without requiring an additional invasive surgical procedure (e.g., due to the smaller size and isodiametric shape of the catheter components without the bioresorbable material 1404 holding them together). The two or more components 1402 can be independently removed from the patient’s body after the PBM therapy is completed, e.g., by pulling them through the percutaneous hole.

[0094] The two or more catheter components 1402 can be held in one or more different predefined positions by the bioresorbable material 1404. Each of the two or more catheter components 1402 can have one or more emitters 102. The different predefined positions can ensure that the one or more emitters 102 can deliver light to a specific target area (e.g., in a fixed spatial orientation relative to one another). In some instances, at least one of the one or more emitters 102 can be positioned epidurally over an injury of the patient’s spinal cord. The one or more emitters 102 can be protected from damage due to biological factors (e.g., moisture) by being substantially covered by a coating 1408 that includes at least one polymer (e.g., paraffin, parylene, silicone, etc.). The two or more catheter components 1402 can also include LEDs, electrical wires, waveguides, and the like within them and can be grouped at a distance from the spinal cord and configured to enter / exit the patient’s body percutaneously. A connector 1406 can be used to connect the grouped two or more components to a controller 106, power source and / or light source.

[0095] In some instances, the catheter- components 1402 may not be fixed together mechanically or by adhesive to enable removal. However, in other instances, at least a portion of the catheter components 1402 may be fixed together mechanically or by adhesive.

[0096] FIG. 15 is a block diagram of still another example system 1500 with a percutaneous device 1502 and at least one light emitting element (emitter(s) 102) that can be implanted in a spinal canal of a patient. The example system 1500 can include the percutaneous device 1502 that can cross the skin from outside a patient’s body to inside the patient’s body. The percutaneous device 1502 can have an internal portion under the patient’s skin, an interface portion 1504 that can traverse the patient’s skin, and an external portion outside the patient’s skin. In some instances, at least a portion of the percutaneous device 1502 can be flexible. In some instances, at least a portion of the percutaneous device 1502 can be encompassed by a catheter and / or can be embodied as a catheter that can cover at least the internal portion and the interface portion 1504 of the percutaneous device (e.g., as shown in at least FIG. 7). In some instances, the interface portion 1504 can include a sterile component configured to be secured to the catheter (inside or outside the body). The sterile component can include mechanical features that prevent or reduce a likelihood of the interface component sliding into and out of the patient’s skin. For example, the interface portion 1504 can include at least one disc shaped edges 1508 that can insert between skin between the disc shaped edges to reduce movement relative to the skin. The interface portion 1504 can, in some instances, also include a covering of at least one antibacterial agent and / or coating.

[0097] The percutaneous device 1502 can also include at least one cable 1506 that can connect the emitter(s) 102 with at least one of a controller 106, an external power source 1510, and / or an external light source 1512. In some instances, the cable(s) 1506 can be encompassed entirely inside the percutaneous device 1502.

[0098] The cable(s) 1506 can be, for example, electrical cables and / or waveguides. The cable(s) 1506, wiring members (not shown), and / or other connections (not shown) between the emitter(s) 102 and the controller 106, external power source 1510, and / or external light source 1512 can travel through the percutaneous device 1502. In some instances, the cable(s) 1506 can transverse the skin without apercutaneous device 502 and the cables themselves may have the features of 1506 and 1508 discussed below. The portion of the percutaneous device 1502 outside the patient’s body can be sized, shaped, and / or configured to allow the cable(s), wiring members and / or other connections to interface with the external power source 1510, external light source 1512, and / or a controller 106. In other instances, the cable(s) 1506 can be outside the percutaneous device 1502 (e.g., can be the interface portion 1504) and can breach the skin barrier. For example, at least a portion of the at least one cable 1506, wiring members, and / or other connections can be wound into a helix shape 1506 and configured to accept skin between turns of the helix shape to prevent the helical shape from sliding out and anchor the at least one cable, wiring members, and / or other connections entering the body percutaneously from sliding. In such instances a dressing (not shown) or the like can be used to at least partially keep the cables from moving and at least partially protect the exit site from infection.

[0099] The emitter(s) 102 (connected to at least the cable(s) 1506) can be implanted in the patient’s spinal canal and positioned to cover at least a portion of the patient’s spinal cord (e.g., an irradiation area / treatment area). In some instances, the emitter(s) 102 can be shaped as a paddle and / or can be on / within a paddle shaped lead. The paddle and / or paddle shaped lead can be flexible. A surface of the paddle and / or paddle shaped lead can be coated with a moisture-resistant polymer such as parylene. In another instance, the emitter(s) 102 can be connected to the internal portion of the percutaneous device 1502. In a further instance, the emitter(s) 102 can include and / or can be attached with a fiber optic cable and / or light tunnel that can be fed through the percutaneous device 1502 into the spinal canal. The emitter(s) 102 can be hermetically sealed in any of the instances.

[0100] FIG. 16 shows a block diagram of another example system 1600 that can be at least partially implanted into a patient’s body to provide PBM therapy. The system 1600 can include at least one component 1602, which can include at least one light emitting element 1604, and at least one other component 1606, which can include a power source 1608 for the at least one component. The system 1600 can also include at least one light sensitive element 1610 that can sense and / or enable sensing of an amount of light emitted being the light emitting element 1604 at a given time. The at least one component 1602, the at least one other component 1606, and the lightsensitive element 1610 can all be implanted into the patient’s body, at same or different locations.

[0101] The at least one component 1602 that includes the at least one light emitting element 1504 can be a paddle having a flexible substrate and the at least one light emitting element can be a one or a plurality of micro-LEDs on and / or within the flexible substrate. The paddle shaped at least one component 1602 can be implanted in the epidural space to provide PBM therapy to at least one portion of the spinal cord. In this case the paddle shaped at least one component 1602 can include a lead connection for a cable at a center of a top or bottom side of the paddle so that the cable can be routed through a space between vertebra (e.g., created by the laminectomy for implanting the at least one component) (e.g., as shown at least in FIG. 10, element B and FIG. 13, element C). This set up can facilitate keeping areas of the spinal cord above and below an injury site / treatment area covered. In another example, the paddle shaped at least one component 1602 can have a lead connection for a cable on a peripheral side of the paddle to allow the cable to exit a vertebrae above or below an injury site of a patient’s spinal cord.

[0102] The light sensitive element(s)1610 (e.g., photodiodes, or the like) can sense and / or enable sensing of an amount of light being emitted by the light emitting element(s) 1604. The light sensitive element(s) 1610 can be located on and / or in the at least one other component 1606 (as shown). In other instances, the light sensitive element(s) 1610 can alternatively and / or additionally be located on and / or in the at least one component 1602 and / or separately positioned on and / or implanted within a portion of the patient’s body (e.g., under the skin, within the spinal canal, etc.) in a location where the light sensitive element(s) can sense light from the light emitting element(s) 1604. The light sensitive element(s) 1610 can receive power, in some instances, from the power source 1608, and / or another power source 1612 such as a separate implanted power source and / or an external power source. It should be understood that the light sensitive element(s) 1610 may be configured to receive power from a certain type of power source (e.g., current, voltage, RF powered, etc.).

[0103] The light sensitive element(s) 1610 can be connected wirelessly and / or by a wire to a controller 1614 and / or an implantable device 1616. The controller 1614 can be located external to the patient and / or can be implanted. The controller 1614 canrecord an amount of light being emitted by the light emitting element(s) 1604 (and received by the light sensing element(s) 1610) at a given time and / or can process recordings of the amount of light being emitted by the light emitting element(s) (and received by the light sensing element(s). In some instances, the light sensitive element(s) 1610 can generate a signal when light is received. For example, the controller 1614 can be configured to adjust an output of the at least one light emitting element based on a manual input from a user. In some instances, the controller 1614 can adjust an output of the light emitting element(s) 1604 based on the recorded and / or processed amount of light being emitted at the given time (e.g., the amount is above a safety threshold and can be lowered, the amount is below an efficacy threshold for the therapy and can be increased, or the like). The controller 1614 can, in other instance, adjust an output of the light emitting element(s) 1604 based on a manual input from a user (e.g., via user interface, not shown). The light sensitive element(s) 1610 and the light emitting element(s) 1604 can also and / or alternatively be couped to (wired and / or wirelessly) an implantable device 1616 (which can be a memory device, another controller, and / or in communication with the controller 1614). In some instances, the implantable device 1616 can be coupled to the light sensitive element(s) 1610 to receive sensed data related to the amount of light being emitted by the at least one light emitting element(s) 1604 to change the output of the at least one light emitting electrode based on the sensed data to achieve an irradiance (e.g., in a feedback loop). In other instances, the implantable device 1616 can be coupled to the light sensitive element(s) 1610 to receive sensed data related to the amount of light being emitted by the at least one light emitting element or the light emitting element(s) 1604 to change the output of the at least one light emitting element based on user input and / or stored instructions (e.g., as separate functions without a feedback component).

[0104] In certain embodiments, it will be appreciated that the systems and devices of the present disclosure can be sized and dimensioned for positioning underneath the layers of tissue extending between a spinal cord and a skin surface (e.g., defining a patient’s back) such that, when the system and / or device is implanted in the patient, there is no intervening tissue between the emitter and the spinal cord.IV. Methods

[0105] Another aspect of the present disclosure can include a method 1700 (FIG.17) for providing PBM to at least a portion of a spinal cord of a patient via at least an implanted light emitting element (e.g., emitter 102). It should be noted that the implanted light emitting element (e.g., emitter 102) can be explanted following the end of the PBM therapy and / or in the event of ineffectiveness (e.g., due to an immune reaction, improper placement, mechanical difficulties, or the like). The system 100 of FIG. 1, and the various implementations shown in FIGS. 2-16, can be used to execute the method 1700.

[0106] At 1702, a light emitting element (e.g., emitter 102) (and / or a device including the light emitting element) can be implanted proximal to (e.g., near, on, and / or within) a spinal column of a patient to irradiate at least a portion of a spinal cord within the spinal column. The implantation of the light emitting element (and / or a device including the light emitting element) can occur in any of the manners shown and described above with respect to FIGS. 1-16. For example, the implantation can occur during and / or after a laminectomy and / or a decompression surgery. In some instances, the light emitting element (and / or a device including the light emitting element) can be implanted directly into the epidural space. In other instances, the light emitting element (and / or a device including the light emitting element) can be positioned outside the epidural space. The light emitting element (and / or a device including the light emitting element) can be implanted near the site of an injury (e.g., a spinal cord injury (SCI)) and / or a secondary site associated with treatment of the SCI. In some instances, no laminectomy and / or decompression surgery is necessary, and the implanting can be accomplished using cannulas to place the light emitting element (and / or a device including the light emitting element) proximal to the site of the injury and / or other treatment site.

[0107] The light emitting element (and / or a device including the light emitting element) can be positioned in the epidural space such that at least a portion of the light is delivered proximal to the site of injury (e.g., in epidural space above the lesion itself). However, the light may be delivered completely to the site of injury or to an area affected by the site of injury that does not include the site of injury itself (e.g., a secondary treatment site). When the light emitting element (and / or a device including the light emitting element) is implanted over the lesion itself, light can be delivered tothe lesion itself to promote healing while blocking invasion by glia and fibroblasts to support neuron survival and neural connectivity. The light emitting element can be configured to emit light to irradiate at least a portion of the spinal cord within the spinal column as discussed herein (e.g., can provide light of one or more wavelengths, pulse states (pulsed or continuous), timing, intensity, locations, etc. depending on the prescribed therapy). The light emitting element can be sized, shaped, dimensioned, positioned, etc., to irradiate a certain portion of the spinal cord, or multiple light emitting elements might be implanted to achieve those purposes.

[0108] At 1704, an injury site within the spinal column can be irradiated according to a prescription that can promote healing of spinal cord injury using photobiomodulation. The prescription can include applying a dose of light emitted by the light emitting element to the treatment location (e.g., the SCI and / or a secondary location) for a time according to a prescription. The dose can be applied to the treatment location (e.g., at least a portion of a nerve, such as an area that includes one or more nodes or Ranvier near the site of the injury to stop myelin damage, a type of secondary damage due to spinal cord injury) for the time to promote healing of the injury. As an example, the dose can include turning at least a portion of the light emitting device on for a time and off for another time to facilitate thermal relaxation. For example, when the injury is a spinal cord injury, application of the dose for the time can reduce secondary damage related to the spinal cord injury.

[0109] At 1706, optionally, at least a portion of the light emitting element can be explanted after the prescription is complete (in other words, when is the therapy is complete). In other instances, the light emitting element can be explanted before the therapy is completed (e.g., before the prescribed time frame) (e.g., when indicated by infection, nerve and / or tissue damage, patient choice, or another indicator). In either instance, the explanting can occur without requiring a surgical procedure or can only require a minimally invasive surgical procedure. Removal of percutaneous elements after the percutaneous elements are no longer useful can significantly decrease infection risk. Hermetic components that are fully implantable may be safely left in the body if no negative reactions have occurred but can also be explanted. Electronic components coated in a moisture-resistant coating can be removed to avoid leaching of unwanted material into the patient’s body. For example, one or more securementmechanisms of the light emitting element in the body can be configured to absorb / resorb over time and / or can be configured to be removably attached within the body (e.g., unscrewing / clamping hardware, cutting sutures, etc.). In another example, a catheter like / tube-like system component can be pulled through a percutaneous hole.

[0110] In certain embodiments, it will be appreciated that the methods of the present disclosure can include positioning the systems and / or devices disclosed herein underneath the layers of tissue extending between a spinal cord and a skin surface (e.g., defining a patient’s back) such that, when the system and / or device is implanted in the patient, there is no intervening tissue between the emitter and the spinal cord.

[0111] Exemplary Aspects

[0112] In view of the described compositions, devices, and methods and variations thereof, herein below are certain more particularly described aspects of the present disclosure. These particularly recited aspects should not, however, be interpreted to have any limiting effect on any different claims containing different or more general teachings described herein, or that the “particular” aspects are somehow limited in some way other than the inherent meanings of the language literally used therein.

[0113] Aspect 1: A system comprising an intracorporeal device configured for implantation within a body of a patient, the device comprising at least one emitter configured to emit light to irradiate at least a portion of a spinal cord within a spinal column of the patient; one or more pieces of orthopedic hardware connected to the device, the one or more pieces of orthopedic hardware being sized and dimensioned for attachment to a location proximal to the spinal column; and a controller in electrical communication with the at least emitter and programmed to define a photobiomodulation (PBM) therapy delivered by the at least one emitter to the at least a portion of the spinal cord.

[0114] Aspect 2: The system of Aspect 1 , wherein the device further comprises a heat dissipator configured to dissipate heat generated by the emitter.

[0115] Aspect 3: The system of any one of Aspects 1-2, wherein the controller further comprises a user interface configured to permit user-definition of at least a portion of the PBM therapy.

[0116] Aspect 4: The system of any one of Aspects 1-3, wherein the controller further comprises a processor that accesses instructions to execute at least onealgorithm that defines at least a portion of the PBM therapy according to closed loop control in response to at least one signal from at least one sensor configured to detect a property of the body of the patient.

[0117] Aspect 5: The system of any one of Aspects 1-4, wherein the closed loop control optimizes one or more outcomes associated with the PBM therapy at least one wavelength and / or at least one irradiance pattern that enables large sections of spinal cord to be irradiated at one or more levels that induce favorable PBM effects.

[0118] Aspect 6: The system of any one of Aspects 1-5, wherein the device is biocompatible and implantable for a time period.

[0119] Aspect 7: The system of any one of Aspects 1-6, wherein the time period is at least seven days.

[0120] Aspect 8: The system of any one of Aspects 1-7, wherein the device further comprises a hermetic package configured to encapsulate at least the emitter and direct the light to irradiate at least a portion of a spinal cord within the spinal column.

[0121] Aspect 9: The system of any one of Aspects 1-8, wherein the device further comprises a cross-link mechanism configured to secure the device to the one or more pieces of orthopedic hardware proximal to the spinal column.

[0122] Aspect 10: The system of any one of Aspects 1-9, wherein the cross-link mechanism comprises a holding mechanism configured to be secured to the one or more pieces of orthopedic hardware at one or more midline positions and / or one or more off mid-line positions relative to the spinal column.

[0123] Aspect 11 : The system of any one of Aspects 1-10, wherein the holding mechanism comprises at least one pedicle screw, at least one set screw-like device, at least one clamp, at least one press fit, at least one adhesive, or at least one nock-like device.

[0124] Aspect 12: The system of any one of Aspects 1-11, wherein the emitter comprises one or more light emitting diodes and / or one or more laser diodes.

[0125] Aspect 13: The system of any one of Aspects 1-12, further comprising an optical feedthrough device configured to interface with a waveguide to receive the light and deliver the light to the at least the portion of the spinal cord within the spinal column.

[0126] Aspect 14: The system of any one of Aspects 1-13, wherein the optical feedthrough or waveguide comprises one or more of a lens, a GRIN lens, a Fresnel lens, a cylindrical lens, a Powell lens, a cylindrical light diffuser, a diffraction grating, a line diffuser, or a micro-lens array.

[0127] Aspect 15: The system of any one of Aspects 1-14, wherein the device further comprises an RF coil configured to receive patient information and / or dosage information from the external controller.

[0128] Aspect 16: The system of any one of Aspects 1-15, wherein the device is configured to receive power from an external device.

[0129] Aspect 17: The system of any one of Aspects 1-16, further comprising a percutaneous interface configured to facilitate a percutaneous electrical connection between the device and the controller.

[0130] Aspect 18: The system of any one of Aspects 1-17, wherein the device is housed in a tube-shaped device.

[0131] Aspect 19: The system of any one of Aspects 1-18, wherein a portion of the tube-shaped device extends percutaneously outside the human body and is connectable to an external light source and / or an external electrical source.

[0132] Aspect 20: The system of any one of Aspects 1-19, wherein the tubeshaped device houses electrical cables that support powering the emitter.

[0133] Aspect 21 : The system of any one of Aspects 1-20, wherein the tubeshaped device is an elongated waveguide.

[0134] Aspect 22: A system comprising at least one paddle shaped lead that is flexible and configured to be positioned within a spinal canal of a patient and having at least one surface configured to deliver light to at least one segment of a spinal cord of the patient, at least one emitter coupled to the at least one surface of the at least one paddle shaped lead and configured to emit light of at least one wavelength, and a power source configured to deliver power to the at least one emitter.

[0135] Aspect 23: The system of Aspect 22, wherein the at least one paddle shaped lead is wider and longer than it is thick and sized and dimensioned to be placed within an epidural space of the spinal canal of the patient.

[0136] Aspect 24: The system of any one of Aspects 22-23, wherein the at least one paddle shaped lead comprises a material that is flexible to adapt to the at least one segment of the patient’s spinal cord.

[0137] Aspect 25: The system of any one of Aspects 22-24, wherein the at least one paddle shaped lead spans two or more segments of the spinal cord of the patient.

[0138] Aspect 26: The system of any one of Aspects 22-25, wherein the at least one emitter comprises one or more light emitting diodes and / or one or more laser diodes.

[0139] Aspect 27: The system of any one of Aspects 22-26, wherein the power source is located internal to the patient and / or an external to the patient.

[0140] Aspect 28: The system of any one of Aspects 22-27, wherein the at least one paddle shaped lead is at least partially encased in a coating having a lower index of refraction than the at least one paddle shaped lead, wherein the coating enables a uniform irradiation pattern of the light.

[0141] Aspect 29: The system of any one of Aspects 22-28, wherein the paddle comprises a plurality of channels that are each encased in the coating to guide the light to locations on the at least one surface configured to deliver the light.

[0142] Aspect 30: The system of any one of Aspects 22-29, wherein the at least one paddle shaped lead comprises at least two paddle shaped leads that each have a longer length than a width and are configured to be placed side-by-side within the spinal canal of the patient.

[0143] Aspect 31 : The system of any one of Aspects 22-30, wherein at least one of the at least two paddle shaped leads is a cylindrical light diffuser.

[0144] Aspect 32: The system of any one of Aspects 22-31 , wherein the at least one emitter comprises at least one light emitting array embedded within a flexible substrate wherein the at least one light emitting array comprises at least two LEDs each configured to deliver the light.

[0145] Aspect 33: The system of any one of Aspects 22-32, wherein the at least one light emitting array is configured to deliver the light with at least two wavelengths concurrently and / or at different times.

[0146] Aspect 34: The system of any one of Aspects 22-33, further comprising a heat management mechanism comprising a material having a high thermalconductivity, at least one thermally conductive element, a hydrogel coating, and / or a phase change material.

[0147] Aspect 35: The system of any one of Aspects 22-34, further comprising at least one diffuser associated with the at least one emitter to achieve a distribution of the light across the at least one segment of the spinal cord of the patient at one or more levels that induce favorable PBM effects.

[0148] Aspect 36: The system of any one of Aspects 22-35, wherein the at least one diffuser is configured to provide a wide beam for more diffuse coverage.

[0149] Aspect 37: The system of any one of Aspects 22-36, wherein the at least one diffuser comprises at least one optical fiber having an angled tip and / or tipped with a diffusing element.

[0150] Aspect 38: The system of any one of Aspects 22-37, wherein the at least one paddle shaped lead further comprises at least one high friction element configured to provide friction between at least one other surface of the paddle shaped lead and a portion of the spinal canal of the patient to prevent migration of the at least one paddle shaped lead.

[0151] Aspect 39: The system of any one of Aspects 22-38, wherein the high friction element is positioned on a dorsal side of the paddle shaped lead and creates friction between the dorsal side of the paddle shaped lead and the spinal canal.

[0152] Aspect 40: The system of any one of Aspects 22-39, wherein the high friction element is positioned on a ventral side of the paddle shaped lead and creates friction between the ventral side of the paddle shaped lead and dura.

[0153] Aspect 41 : The system of any one of Aspects 22-40, wherein the high friction element comprises a bioresorbable material that decreases the friction over time to enable easier explant of at least a portion of the paddle.

[0154] Aspect 42: The system of any one of Aspects 22-41, further comprising at least one tether point in the paddle shaped lead that facilitates fixing the paddle shaped lead into place in the spinal canal.

[0155] Aspect 43: An implantable paddle comprising two or more catheter components with at least one emitter within each of the two or more catheter components, and a bioresorbable material holding the two or more catheter components in positions relative to one another.

[0156] Aspect 44: The implantable paddle of Aspect 43, wherein at least the two or more catheter components are sized and dimensioned to be placed within a patient’s spinal canal.

[0157] Aspect 45: The implantable paddle of any one of Aspects 43-44, wherein the at least one emitter is positioned epidurally over an injury of a patient’s spinal cord.

[0158] Aspect 46: The implantable paddle of any one of Aspects 43-45, wherein the two or more catheter components further comprise electrical wires and / or waveguides and can be grouped at a distance from the spinal cord and configured to enter / exit the patient’s body percutaneously.

[0159] Aspect 47: The implantable paddle of any one of Aspects 43-46, further comprising a distal connector configured to connect the grouped two or more catheter components to a power source and / or light source.

[0160] Aspect 48: The implantable paddle of any one of Aspects 43-47, wherein the two or more catheter components are arrangeable in a patient’s spinal canal such that the at least one emitter on each catheter component is arranged in a fixed relative spatial orientation to another.

[0161] Aspect 49: The implantable paddle of any one of Aspects 43-48, wherein the bioresorbable material is configured to resorb into the body of the patient after a time, and after the bioresorbable material has resorbed, the two or more catheter components are configured to be removeable from the body of the patient without additional surgery.

[0162] Aspect 50: The implantable paddle of any one of Aspects 43-49, wherein the at least one emitter is protected from moisture by a coating comprising at least one polymer.

[0163] Aspect 51 : A system configured for implantation into a patient’s body, the system comprising at least one component comprising at least one light emitting element, at least one other component comprising a power source for the at least one component, and at least one light sensitive element that enables sensing of an amount of light being emitted by the light emitting element.

[0164] Aspect 52: The system of Aspect 51, wherein the at least one light sensitive element comprises at least one photodiode.

[0165] Aspect 53: The system of any one of Aspects 51-52, wherein the at least one light sensitive element is located on and / or in and / or near the at least one other component.

[0166] Aspect 54: The system of any one of Aspects 51-53, wherein the at least one light sensitive element receives power from the power source, a separate implanted power source, or an external power source.

[0167] Aspect 55: The system of any one of Aspects 51-54, wherein the at least one light sensitive element is configured to be connected wirelessly and / or by a wire to a controller that records an amount of light being emitted by the at least one light emitting element and / or processes recordings of the amount of light being emitted by the at least one light emitting element.

[0168] Aspect 56: The system of any one of Aspects 51-55, wherein the controller is located external to the patient and configured to adjust an output of the at least one light emitting element based on a manual input from a user.

[0169] Aspect 57: The system of any one of Aspects 51-56, further comprising an implantable device coupled to the at least one light sensitive element to receive sensed data related to the amount of light being emitted by the at least one light emitting element and the at least one light emitting element to change the output of the at least one light emitting electrode based on the sensed data to achieve an irradiance.

[0170] Aspect 58: The system of any one of Aspects 51-57, wherein the at least one component comprising the at least the light emitting element is a paddle comprising a flexible substrate and at least one or a plurality of micro-LEDs on and / or within the flexible substrate.

[0171] Aspect 59: The system of any one of Aspects 51-58, wherein the at least one component further comprises a lead connection for a cable at a center of a top or bottom side of the paddle so that the cable is routed through a space created by a laminectomy for implanting at least the at least one component while keeping areas above and below an injury site of a patient covered.

[0172] Aspect 60: The system of any one of Aspects 51-59, wherein the at least one component further comprises a lead connection for a cable on a peripheral side of the paddle to allow the cable to exit a vertebrae above or below an injury site of a patient’s spinal cord.

[0173] Aspect 61 : A system comprising a percutaneous device with an internal portion under a patient’s skin, an interface portion that traverses the patient’s skin, and an external portion outside the patient’s skin, the percutaneous device comprises at least one cable configured to connect to an external power and / or light source, and at least one light emitting element configured to be implanted in a spinal canal of the patient and positioned to cover an irradiation area of a spinal cord of the patient and connected to the at least one cable to receive power and / or light from the external power and / or light source.

[0174] Aspect 62: The system of Aspect 61, wherein at least a portion of the at least one cable is wound into a helix shape and configured to accept skin between turns of the helix shape to anchor the at least one cable entering the body percutaneously from sliding.

[0175] Aspect 63: The system of any one of Aspects 61-62, wherein the at least one cable is an electrical cable and / or a waveguide.

[0176] Aspect 64: The system of any one of Aspects 61-63, further comprising a catheter that covers at least the internal portion and the interface portion of the percutaneous device.

[0177] Aspect 65: The system of any one of Aspects 61-64, wherein the interface portion comprises a sterile component configured to be secured to the catheter, wherein the sterile component includes mechanical features that prevent or reduce a likelihood of the interface component sliding into and out of the skin of the patient.

[0178] Aspect 66: The system of any one of Aspects 61-65, wherein the interface portion has at least one disc shaped edge configured such that skin is able to insert between the edges to reduce movement relative to the skin.

[0179] Aspect 67: The system of any one of Aspects 61-66, wherein the interface portion further comprises a covering of an antibacterial agent and / or coating.

[0180] Aspect 68: The system of any one of Aspects 61-67, wherein the at least one light emitting element is hermetically sealed.

[0181] Aspect 69: The system of any one of Aspects 61-68, wherein the at least one light emitting element is shaped as a paddle, wherein a surface of the paddle is coated with a moisture-resistant polymer.

[0182] Aspect 70: A method comprising implanting a light emitting element in a patient’s body proximal to a spinal column near a site of an injury, wherein the light emitting element is configured to emit light to irradiate at least a portion of a spinal cord within the spinal column, irradiating the injury site with a dose for a time according to a prescription to promote healing of the injury, and explanting at least a portion of the light emitting element after the prescription is complete.

[0183] Aspect 71: The method of Aspect 70, wherein irradiating further comprises delivering light to at least one node of Ranvier near the site of the injury.

[0184] Aspect 72: The method of any one of Aspects 70-71, wherein the implanting further comprises implanting the light emitting element in the patient’s body after a laminectomy and / or during a stabilization and / or decompression surgery.

[0185] Aspect 73: The method of any one of Aspects 70-72, wherein the implanting further comprises implanting the light emitting element in the patient’s body using cannulas to place the light emitting element proximal to the site of the injury.

[0186] Aspect 74: The method of any one of Aspects 70-73, wherein the explanting further comprises explanting at least the portion of the light emitting element without requiring a surgical procedure.

[0187] Aspect 75: The method of any one of Aspects 70-74, wherein the implanting further comprises positioning the light emitting element in epidural space such that at least a portion of the light is delivered proximal to the site of the injury.

[0188] Aspect 76: The method of any one of Aspects 70-75, further comprising positioning the light emitting device in epidural space over a lesion itself to promote healing while inhibiting invasion by glia and fibroblasts to support neuron survival and neural connectivity.

[0189] Aspect 77: The method of any one of Aspects 70-76, further comprising turning at least a portion of the light emitting element on for a time and off for another time to facilitate thermal relaxation.

[0190] Aspect 78: The system of any one of Aspects 1-21, wherein the controller is an extracorporeal controller.

[0191] From the above description, those skilled in the art will perceive improvements, changes, and modifications. Such improvements, changes andmodifications are within the skill of one in the art and are intended to be covered by the appended claims.

Claims

CLAIMS1. A system comprising:an intracorporeal device configured for implantation within a body of a patient, the device comprising at least one emitter configured to emit light to irradiate at least a portion of a spinal cord within a spinal column of the patient;one or more pieces of orthopedic hardware connected to the device, the one or more pieces of orthopedic hardware being sized and dimensioned for attachment to a location proximal to the spinal column; anda controller in electrical communication with the at least emitter and programmed to define a photobiomodulation (PBM) therapy delivered by the at least one emitter to the at least a portion of the spinal cord.

2. The system of claim 1 , wherein the device further comprises a heat dissipator configured to dissipate heat generated by the at least one emitter.

3. The system of claim 1 , wherein the controller further comprises a user interface configured to permit user-definition of at least a portion of the PBM therapy.

4. The system of claim 1 , wherein the controller further comprises a processor that accesses instructions to execute at least one algorithm that defines at least a portion of the PBM therapy according to closed loop control in response to at least one signal from at least one sensor configured to detect a property of the body of the patient.

5. The system of claim 4, wherein the closed loop control optimizes one or more outcomes associated with the PBM therapy at least one wavelength and / or at least one irradiance pattern that enables large sections of the spinal cord to be irradiated at one or more levels that induce favorable PBM effects.

6. The system of claim 1 , wherein the device is biocompatible and implantable for a time period.

7. The system of claim 6, wherein the time period is at least seven days.

8. The system of claim 1, wherein the device further comprises a hermetic package configured to encapsulate at least the at least one emitter and direct the light to irradiate the at least a portion of a spinal cord.

9. The system of claim 1 , wherein the one or more pieces of orthopedic hardware further comprise a cross-link mechanism configured to secure the device to the one or more pieces of orthopedic hardware.

10. The system of claim 9, wherein the cross-link mechanism comprises a holding mechanism configured to be secured to the one or more pieces of orthopedic hardware at one or more midline positions and / or one or more off mid-line positions relative to the spinal column.

11. The system of claim 10, wherein the holding mechanism comprises at least one pedicle screw, at least one set screw-like device, at least one clamp, at least one press fit component, at least one adhesive, or at least one nock-like device.

12. The system of claim 1 , wherein the at least one emitter comprises one or more light emitting diodes and / or one or more laser diodes.

13. The system of claim 1, further comprising an optical feedthrough device configured to interface with a waveguide to receive the light and deliver the light to the at least a portion of the spinal cord.

14. The system of claim 13, wherein the optical feedthrough or waveguide comprises one or more of a lens, a GRIN lens, a Fresnel lens, a cylindrical lens, a Powell lens, a cylindrical light diffuser, a diffraction grating, a line diffuser, or a microlens array.

15. The system of claim 1, wherein the device further comprises an RF coil configured to receive patient information and / or dosage information from the controller.

16. The system of claim 1 , wherein the device is configured to receive power from an external device.

17. The system of claim 1, further comprising a percutaneous interface configured to facilitate a percutaneous electrical connection between the device and the controller.

18. The system of claim 1, wherein the device is housed in a tube-shaped device.

19. The system of claim 18, wherein a portion of the tube-shaped device extends percutaneously outside the patient and is connectable to an external light source and / or an external electrical source.

20. The system of claim 18, wherein the tube-shaped device houses electrical cables that support powering the at least one emitter.

21. The system of claim 18, wherein the tube-shaped device is an elongated waveguide.

22. A system comprising:at least one paddle shaped lead that is flexible and configured to be positioned within a spinal canal of a patient and having at least one surface configured to deliver light to at least one segment of a spinal cord of the patient;at least one emitter coupled to the at least one surface of the at least one paddle shaped lead and configured to emit light of at least one wavelength; anda power source configured to deliver power to the at least one emitter.

23. The system of claim 22, wherein the at least one paddle shaped lead is wider and longer than it is thick and sized and dimensioned to be placed within an epidural space of the spinal canal of the patient.

24. The system of claim 23, wherein the at least one paddle shaped lead comprises a material that is flexible to adapt to the at least one segment of the patient’s spinal cord.

25. The system of claim 23, wherein the at least one paddle shaped lead spans two or more segments of the spinal cord of the patient.

26. The system of claim 22, wherein the at least one emitter comprises one or more light emitting diodes and / or one or more laser diodes.

27. The system of claim 22, wherein the power source is located internal to the patient or an external to the patient.

28. The system of claim 22, wherein the at least one paddle shaped lead is at least partially encased in a coating having a lower index of refraction than the at least one paddle shaped lead, wherein the coating enables a uniform irradiation pattern of the light.

29. The system of claim 28, wherein the paddle comprises a plurality of channels that are each encased in the coating to guide the light to locations on the at least one surface configured to deliver the light.

30. The system of claim 22, wherein the at least one paddle shaped lead comprises at least two paddle shaped leads that each have a longer length than a width and are configured to be placed side-by-side within the spinal canal of the patient.

31. The system of claim 29, wherein at least one of the at least two paddle shaped leads is a cylindrical light diffuser.

32. The system of claim 22, wherein the at least one emitter comprises at least one light emitting array embedded within a flexible substrate wherein the at least one light emitting array comprises at least two LEDs each configured to deliver the light.

33. The system of claim 32, wherein the at least one light emitting array is configured to deliver the light with at least two wavelengths concurrently and / or at different times.

34. The system of claim 22, further comprising a heat management mechanism comprising a material having a high thermal conductivity, at least one thermally conductive element, a hydrogel coating, and / or a phase change material.

35. The system of claim 22, further comprising at least one diffuser associated with the at least one emitter to achieve a distribution of the light across the at least one segment of the spinal cord of the patient at one or more levels that induce favorable PBM effects.

36. The system of claim 35, wherein the at least one diffuser is configured to provide a wide beam for more diffuse coverage.

37. The system of claim 35, wherein the at least one diffuser comprises at least one optical fiber having an angled tip and / or tipped with a diffusing element.

38. The system of claim 22, wherein the at least one paddle shaped lead further comprises at least one high friction element configured to provide friction between at least one other surface of the paddle shaped lead and a portion of the spinal canal of the patient to prevent migration of the at least one paddle shaped lead.

39. The system of claim 38, wherein the high friction element is positioned on a dorsal side of the paddle shaped lead and creates friction between the dorsal side of the paddle shaped lead and the spinal canal.

40. The system of claim 38, wherein the high friction element is positioned on a ventral side of the paddle shaped lead and creates friction between the ventral side of the paddle shaped lead and dura.

41. The system of claim 38, wherein the high friction element comprises a bioresorbable material that decreases the friction over time to enable easier explant of at least a portion of the paddle.

42. The system of claim 22, further comprising at least one tether point in the paddle shaped lead that facilitates fixing the paddle shaped lead into place in the spinal canal.

43. An implantable paddle comprising:two or more catheter components with at least one emitter within each of the two or more catheter components; anda bioresorbable material holding the two or more catheter components in positions relative to one another.

44. The implantable paddle of claim 43, wherein at least the two or more catheter components are sized and dimensioned to be placed within a patient’s spinal canal.

45. The implantable paddle of claim 43, wherein the at least one emitter is positioned epidurally over an injury of a patient’s spinal cord.

46. The implantable paddle of claim 45, wherein the two or more catheter components further comprise electrical wires and / or waveguides and can be grouped at a distance from the spinal cord and configured to enter / exit the patient’s body percutaneously.

47. The implantable paddle of claim 46, further comprising a distal connector configured to connect the grouped two or more catheter components to a power source and / or light source.

48. The implantable paddle of claim 43, wherein the two or more catheter components are arrangeable in a patient’s spinal canal such that the at least one emitter on each catheter component is arranged in a fixed relative spatial orientation to another.

49. The implantable paddle of claim 43, wherein the bioresorbable material is configured to resorb into the body of the patient after a time, and after the bioresorbable material has resorbed, the two or more catheter components are configured to be removeable from the body of the patient without additional surgery.

50. The implantable paddle of claim 43, wherein the at least one emitter is protected from moisture by a coating comprising at least one polymer.

51. A system configured for implantation into a patient’s body, the system comprising:at least one component comprising at least one light emitting element;at least one other component comprising a power source for the at least one component; andat least one light sensitive element that enables sensing of an amount of light being emitted by the at least one light emitting element.

52. The system of claim 51 , wherein the at least one light sensitive element comprises at least one photodiode.

53. The system of claim 51 , wherein the at least one light sensitive element is located on and / or in and / or near the at least one other component.

54. The system of claim 51 , wherein the at least one light sensitive element receives power from the power source, a separate implanted power source, or an external power source.

55. The system of claim 51 , wherein the at least one light sensitive element is configured to be connected wirelessly and / or by a wire to a controller that records an amount of light being emitted by the at least one light emitting element and / or processes recordings of the amount of light being emitted by the at least one light emitting element.

56. The system of clam 55, wherein the controller is located external to the patient and configured to adjust an output of the at least one light emitting element based on a manual input from a user.

57. The system of claim 51 , further comprising an implantable device coupled to: the at least one light sensitive element to receive sensed data related to the amount of light being emitted by the at least one light emitting element, andthe at least one light emitting element to change the output of the at least one light emitting electrode based on the sensed data to achieve an irradiance.

58. The system of claim 51 , wherein the at least one component comprising the at least the light emitting element is a paddle comprising a flexible substrate and at least one or a plurality of micro-LEDs on and / or within the flexible substrate.

59. The system of claim 58, wherein the at least one component further comprises a lead connection for a cable at a center of a top or bottom side of the paddle so that the cable is routed through a space created by a laminectomy for implanting at least the at least one component while keeping areas above and below an injury site of a patient covered.

60. The system of claim 58, wherein the at least one component further comprises a lead connection for a cable on a peripheral side of the paddle to allow the cable to exit a vertebrae above or below an injury site of a patient’s spinal cord.

61. A system comprising:a percutaneous device with an internal portion under a patient’s skin, an interface portion that traverses the patient’s skin, and an external portion outside the patient’s skin, the percutaneous device comprises at least one cable configured to connect to an external power and / or light source; andat least one light emitting element configured to be implanted in a spinal canal of the patient and positioned to cover an irradiation area of a spinal cord of the patient and connected to the at least one cable to receive power and / or light from the external power and / or light source.

62. The system of claim 61 , wherein at least a portion of the at least one cable is wound into a helix shape and configured to accept skin between turns of the helix shape to anchor the at least one cable entering the body percutaneously from sliding.

63. The system of claim 61 , wherein the at least one cable is an electrical cable and / or a waveguide.

64. The system of claim 61 , further comprising a catheter that covers at least the internal portion and the interface portion of the percutaneous device.

65. The system of claim 64, wherein the interface portion comprises a sterile component configured to be secured to the catheter, wherein the sterile component includes mechanical features that prevent or reduce a likelihood of the interface component sliding into and out of the skin of the patient.

66. The system of claim 61 , wherein the interface portion has at least one disc shaped edge configured such that skin is able to insert between the edges to reduce movement relative to the skin.

67. The system of claim 61 , wherein the interface portion further comprises a covering of an antibacterial agent and / or coating.

68. The system of claim 61 , wherein the at least one light emitting element is hermetically sealed.

69. The system of claim 61 , wherein the at least one light emitting element is shaped as a paddle, wherein a surface of the paddle is coated with a moisture-resistant polymer.

70. A method comprising:implanting a light emitting element in a patient’s body proximal to a spinal column near a site of an injury, wherein the light emitting element is configured to emit light to irradiate at least a portion of a spinal cord within the spinal column;irradiating the injury site with a dose for a time according to a prescription to promote healing of the injury; andexplanting at least a portion of the light emitting element after the prescription is complete.

71. The method of claim 70, wherein irradiating further comprises delivering light to at least one node of Ranvier near the site of the injury.

72. The method of claim 70, wherein the implanting further comprises implanting the light emitting element in the patient’s body after a laminectomy and / or during a stabilization and / or decompression surgery.

73. The method of claim 70, wherein the implanting further comprises implanting the light emitting element in the patient’s body using cannulas to place the light emitting element proximal to the site of the injury.

74. The method of claim 70, wherein the explanting further comprises explanting at least the portion of the light emitting element without requiring a surgical procedure.

75. The method of claim 70, wherein the implanting further comprises positioning the light emitting element in epidural space such that at least a portion of the light is delivered proximal to the site of the injury.

76. The method of claim 70, further comprising positioning the light emitting device in epidural space over a lesion itself to promote healing while inhibiting invasion by glia and fibroblasts to support neuron survival and neural connectivity.

77. The method of claim 70, further comprising turning at least a portion of the light emitting element on for a time and off for another time to facilitate thermal relaxation.